Malaise and fatigue

R18_MALAI_FATIG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R53 Hospital discharge: ICD-9 — 7807 Hospital discharge: ICD-8 — 79010 Cause of death: ICD-10 — R53 Cause of death: ICD-9 — 7807 Cause of death: ICD-8 — 79010 2 out of 7 registries used, show all original rules.	32809
4. Check minimum number of events None	32809
5. Include endpoints None	32809
6. Filter based on genotype QC (FinnGen only)	31709

Control definitions (FinnGen only)

Control exclude: R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy: 3
Special: FATIGUE
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R50-R69
Name in latin: Aegritudo et lassitudo

NAME	R18_MALAI_FATIG
CONTROL_EXCLUDE	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R53
HD_ICD_9	7807
HD_ICD_8	79010
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R53
COD_ICD_9	7807
COD_ICD_8	79010
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malaise and fatigue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	31709	17761	13948
Unadjusted period prevalence (%)	6.34	6.30	6.39
Median age at first event (years)	71.16	68.83	74.12

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
30086: Matched controls
242081

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R51

ICD-10 Finland

Headache

3.3

323.3

1366

3464

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.7

320.9

815

1426

N05BA12

ATC

alprazolam; oral

2.3

320.7

2864

10698

A10AE04

ATC

insulin glargine; parenteral

2.3

320.1

2854

10653

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

320.0

2089

6757

SPAT1262

SPAT

Handing over of treatment supplies

1.9

319.3

4984

22928

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.7

318.9

1927

5993

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.3

318.6

908

1746

R5110, ,

SPAT

2.6

318.5

2012

6401

R52.1

ICD-10 Finland

Chronic intractable pain

28.6

317.2

250

A02BA02

ATC

ranitidine; systemic

1.9

316.9

5358

25285

R00.2

ICD-10 Finland

Palpitations

2.5

315.8

2291

7797

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

314.3

1261

3095

D09

ICPC

Nausea

3.1

313.4

1437

3832

ZXA05

NOMESCO Finland

Left side

1.7

313.2

6863

34996

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.0

311.9

1543

4302

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

308.4

1778

5393

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

307.9

1588

4533

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.5

307.9

2211

7485

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.1

307.7

9942

33207

SPAT1234

SPAT

Support of social functional capacity

4.3

307.7

2136

4264

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

64.3

307.7

230

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

307.7

3606

11640

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

307.7

1399

3503

A06AD11

ATC

lactulose; oral

3.3

307.7

6011

17168

C08CA01

ATC

amlodipine; oral

1.9

307.7

11233

58492

N06AX21

ATC

duloxetine; oral

3.2

307.7

3982

10888

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

307.7

5376

19257

N03AF02

ATC

oxcarbazepine; oral

5.0

307.7

962

1583

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.6

307.7

2951

7192

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

16.7

307.7

416

203

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

307.7

4488

18252

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

307.7

5306

20555

R13

ICD-10 Finland

Dysphagia

2.7

307.7

2045

6413

S01.0

ICD-10 Finland

Open wound of scalp

2.7

307.7

2580

8040

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

307.7

2563

8247

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

307.7

6644

29712

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

307.7

7140

34221

R56.8

ICD-10 Finland

Other and unspecified convulsions

162.9

307.7

1773

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.6

307.7

634

786

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

307.7

16128

66620

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.5

307.7

5451

14314

R55

ICD-10 Finland

Syncope and collapse

21.9

307.7

4479

1915

R42

ICD-10 Finland

Dizziness and giddiness

3.4

307.7

9332

28324

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

307.7

1982

6053

R50.9

ICD-10 Finland

Fever, unspecified

9.4

307.7

5437

5527

R52.9

ICD-10 Finland

Pain, unspecified

3.1

307.7

2911

8117

R41.0

ICD-10 Finland

Disorientation, unspecified

5.8

307.7

1471

2144

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

307.7

3465

11542

U04

ICPC

Incontinence urine

3.3

307.7

1837

4718

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.3

307.7

7463

30204

N30.0

ICD-10 Finland

Acute cystitis

2.7

307.7

5824

19521

N30.9

ICD-10 Finland

Cystitis, unspecified

3.2

307.7

2228

5973

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.2

307.7

2556

6741

SPAT1216

SPAT

Assessment of functional ability

2.8

307.7

5717

18723

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

7.2

307.7

571

651

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

307.7

9831

36498

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

307.7

3586

10958

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

307.7

5538

23665

A04

ICPC

Weakness/tiredness general

3.9

307.7

6745

16660

A01

ICPC

Pain general/multiple sites

3.1

307.7

3199

8896

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

307.7

2809

9384

R02

ICPC

Shortness of breath/dyspnoea

2.4

307.7

4177

15012

R52.2

ICD-10 Finland

Other chronic pain

6.6

307.7

1105

1401

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.0

307.7

1614

3419

N05AX08

ATC

risperidone; systemic

4.0

307.7

3709

8152

R60.0

ICD-10 Finland

Localized oedema

4.0

307.7

4048

9056

C07AB07

ATC

bisoprolol; oral

2.5

307.7

16149

77579

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.0

307.7

1777

4978

J01FF01

ATC

clindamycin; systemic

1.8

307.7

7376

37343

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

307.7

5502

23026

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.2

307.7

7933

33558

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

10204

37976

J01MA12

ATC

levofloxacin; systemic

2.3

307.7

5633

22411

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

307.7

4270

15080

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

307.7

11801

51734

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

307.7

4150

16465

Z3231

NOMESCO Finland

Registered nurse

2.2

307.7

8955

38797

WX892

NOMESCO Finland

Monitored bed care

3.1

307.7

2614

7226

N05AH03

ATC

olanzapine; systemic

4.3

307.7

2471

4931

N02AA05

ATC

oxycodone; systemic

3.3

307.7

6676

19068

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.2

307.7

1588

4127

N06AB04

ATC

citalopram; systemic

2.5

307.7

7159

26528

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

307.7

6525

29504

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

307.7

2218

7127

G72.8

ICD-10 Finland

Other specified myopathies

6.1

307.7

653

875

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

307.7

8017

40514

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

5.1

307.7

2751

4655

G30.1

ICD-10 Finland

Alzheimer disease with late onset

2.9

307.7

2199

6378

N03AF01

ATC

carbamazepine; oral, rectal

3.3

307.7

1524

3893

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.1

307.7

2038

5492

C03CA01

ATC

furosemide; systemic

3.2

307.7

12061

41731

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.4

307.7

624

799

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

307.7

5374

19474

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

307.7

10382

47624

R03BB04

ATC

tiotropium bromide; inhalant

2.2

307.7

3072

11750

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

307.7

1905

5547

XF404

NOMESCO Finland

Ambulatory ECG

2.7

307.7

2722

8683

C07AA05

ATC

propranolol; systemic

2.0

307.7

5768

25608

N03AX09

ATC

lamotrigine; oral

4.4

307.7

1615

3051

B01AC04

ATC

clopidogrel; oral

2.2

307.7

5055

20216

N03AX14

ATC

levetiracetam; systemic

6.3

307.7

968

1269

P20

ICPC

Memory disturbance

2.7

307.7

4769

15702

R53

ICD-10 Finland

Malaise and fatigue

834.6

307.7

29695

20191

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

307.7

6438

27282

C10AA01

ATC

simvastatin; oral

1.7

307.7

12041

68180

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.1

307.7

1022

2067

S06.0

ICD-10 Finland

Concussion

3.2

307.7

3901

10889

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

15221

92104

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

12092

62139

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

307.7

2989

7792

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

307.7

2819

9297

N02BE01

ATC

paracetamol; systemic, rectal

2.8

307.7

26602

177385

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

307.7

3700

14521

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

307.7

7388

27555

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

307.7

10605

59374

G44.2

ICD-10 Finland

Tension-type headache

2.6

307.7

3954

13513

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.7

307.7

1449

3281

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

8242

40549

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.1

307.7

687

795

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

307.7

4570

12916

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

11878

68820

J01MA02

ATC

ciprofloxacin; systemic

2.0

307.7

11912

59765

Z2221

NOMESCO Finland

Medical doctor

1.8

307.7

7974

39960

Z3226

NOMESCO Finland

Physiotherapist

2.2

307.7

5696

22828

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

307.7

7947

36046

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

307.7

2033

5473

F03

ICD-10 Finland

Unspecified dementia

3.6

307.7

1747

4028

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.9

307.7

6460

21139

N05AX12

ATC

aripiprazole; systemic

4.0

307.7

1326

2751

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

307.7

8680

46320

N06AA09

ATC

amitriptyline; systemic

2.7

307.7

2911

9281

N17

ICPC

Vertigo/dizziness

2.6

307.7

4063

13730

A02BC05

ATC

esomeprazole; systemic

1.9

307.7

11662

61543

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.9

307.7

2006

2910

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.0

307.7

2477

6959

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

307.7

7214

35592

N03AE01

ATC

clonazepam; systemic

3.7

307.7

1960

4478

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.8

307.7

1480

3242

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.3

307.7

1078

2056

B01AF02

ATC

apixaban; oral

2.3

307.7

3867

14739

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.9

307.7

8458

18062

TAB00

NOMESCO Finland

Lumbar puncture

3.8

307.7

1354

2991

A02BC02

ATC

pantoprazole; systemic

2.5

307.7

21195

117468

P29

ICPC

Psychological sympt/compl other

2.7

307.7

2038

6295

K59.0

ICD-10 Finland

Constipation

2.9

307.7

1876

5468

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.8

307.7

11435

43373

R06.0

ICD-10 Finland

Dyspnoea

2.8

307.7

9694

35033

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

307.7

5974

18722

A02BC01

ATC

omeprazole; systemic

1.9

307.7

8161

39238

N06AX11

ATC

mirtazapine; oral

2.7

307.7

11832

47050

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

307.7

3333

12674

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

307.7

5921

22883

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.1

307.7

2434

6739

207

Kela drug reimbursment

Chronic arrhythmias

2.1

307.7

4836

20044

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

307.7

6292

27321

E86

ICD-10 Finland

Volume depletion

8.2

307.7

1348

1383

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

307.7

10272

53831

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

307.7

1233

2849

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

307.7

3476

12843

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.3

307.7

3139

8163

A28

ICPC

Limited function/disability NOS

4.1

307.7

7761

19069

N05CF01

ATC

zopiclone; oral

2.3

307.7

10667

47178

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.5

307.7

1527

2853

AA1AD

NOMESCO Finland

CT of head and brain

4.6

307.7

11978

30305

UJF32

NOMESCO Finland

Coloscopy

2.1

307.7

7948

35036

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.6

307.7

2930

9759

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

307.7

1929

4478

W19

ICD-10 Finland

Unspecified fall

2.6

307.7

3240

10624

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.3

307.7

1686

3278

ZXE00

NOMESCO Finland

One hour or less

1.7

307.7

10959

60786

N06DA03

ATC

rivastigmine; oral, transdermal

3.4

307.7

1577

3896

ZX120

NOMESCO Finland

Intravenous

2.5

307.7

2778

9376

B01AB05

ATC

enoxaparin; parenteral

1.8

307.7

8862

45296

I10

ICD-10 Finland

Essential (primary) hypertension

1.9

307.7

17760

104555

WX002

NOMESCO Finland

Sedation and analgesia

2.0

307.7

5599

25006

AN1

Coronary angiography

2.2

307.7

3287

12554

K92.1

ICD-10 Finland

Melaena

2.9

307.7

1745

5018

SPAT1167

SPAT

Insertion of urinary catheter

4.1

307.7

1204

2460

R33

ICD-10 Finland

Retention of urine

3.1

307.7

3024

8535

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

307.7

2661

9121

J01EA01

ATC

trimethoprim; systemic

1.8

307.7

7626

37800

TKC20

NOMESCO Finland

Catheterisation of bladder

3.1

307.7

2531

6950

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.6

307.7

2313

5422

JN4AD

NOMESCO Finland

Body CT examination

2.5

307.7

2922

10061

R4110

NOMESCO Finland

Physiotherapy

2.1

307.7

8615

38468

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

307.7

5043

20452

Z51.5

ICD-10 Finland

Palliative care

3.2

307.7

2753

7352

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

10120

51241

R11

ICD-10 Finland

Nausea and vomiting

4.5

307.7

3848

7668

SPAT1301

SPAT

No procedures

1.9

307.7

9561

47059

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.6

307.7

2904

9682

N06AB10

ATC

escitalopram; oral

2.3

307.7

6303

25253

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

307.7

4658

14049

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.2

307.7

2154

5757

JN4BD

NOMESCO Finland

Extensive body CT

2.4

307.7

2948

10455

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

307.7

2558

6610

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

6146

29194

N03AG01

ATC

valproic acid; systemic, rectal

5.0

307.7

2342

4055

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

307.7

2333

7714

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

307.7

5459

23654

N05BA01

ATC

diazepam; systemic, rectal

2.8

307.7

4489

14301

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.8

307.7

1614

3537

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.7

307.7

3458

11268

I95.1

ICD-10 Finland

Orthostatic hypotension

6.8

307.7

1855

2324

Z2446

NOMESCO Finland

Social worker

3.6

307.7

2368

5668

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.6

307.7

1362

3186

SPAT1172

SPAT

Guidance concerning hydration

4.5

307.7

878

1620

N05AF03

ATC

chlorprothixene; systemic

4.5

307.7

918

1695

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.9

307.7

1852

5369

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.3

307.7

1249

2395

N06AB03

ATC

fluoxetine; oral

2.2

307.7

3604

13946

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

307.7

7461

37858

XF600

NOMESCO Finland

Bloodpressure measurement

3.4

307.7

2211

5576

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

307.7

2828

10010

Z71.8

ICD-10 Finland

Other specified counselling

1.7

307.7

8380

44601

C07AB02

ATC

metoprolol; systemic

1.9

307.7

6122

28492

SPAT1229

SPAT

Assessment of need for aid

3.5

307.7

2917

7247

A02BC03

ATC

lansoprazole; oral

1.8

307.7

8020

40997

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.7

307.7

4625

9070

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.0

307.7

2706

7632

ZXA00

NOMESCO Finland

Right side

1.7

307.7

7337

37807

N06AX16

ATC

venlafaxine; oral

2.8

307.7

4601

14615

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.8

307.7

1869

5611

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.2

307.7

6161

17845

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.1

307.7

5859

17579

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.8

307.7

4928

9523

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

307.7

2851

10308

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

307.7

9441

48464

R60.9

ICD-10 Finland

Oedema, unspecified

4.2

307.7

1713

3415

SPAT1053

SPAT

Memory test

2.2

307.7

4562

18332

C03DA01

ATC

spironolactone; oral

2.5

307.7

3980

13902

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

12834

65187

S97

ICPC

Chronic ulcer skin

3.1

307.7

1945

5297

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.5

307.7

3768

9537

ZY010

NOMESCO Finland

Hospital outpatient

3.1

307.7

1538

4145

C01DA14

ATC

isosorbide mononitrate; oral

2.3

307.7

5284

20372

N05AH04

ATC

quetiapine; oral

3.4

307.7

6914

19397

F05.9

ICD-10 Finland

Delirium, unspecified

6.3

307.7

972

1267

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

307.7

3154

9253

B01AA03

ATC

warfarin; systemic

2.3

307.7

6380

25624

N03AX16

ATC

[U] pregabalin

2.7

307.7

7658

27313

SPAT1254

SPAT

Administration of medicine

3.0

307.7

5675

17639

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

3.5

307.7

1286

3032

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.1

307.7

3889

11111

K59.09

ICD-10 Finland

Constipation, unspecified

3.7

307.7

2589

6065

N03AX12

ATC

[U] gabapentin; oral

2.7

307.7

5172

17270

N05CD07

ATC

temazepam; oral

2.5

307.7

4076

14258

C09AA05

ATC

ramipril; oral

1.9

307.7

7414

35664

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

7869

41055

R52.0

ICD-10 Finland

Acute pain

4.7

307.7

859

1489

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.1

307.7

7038

31224

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

307.7

4006

16915

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.9

307.7

1599

3445

H02AB06

ATC

prednisolone; systemic

1.9

307.7

13945

75278

N05AA02

ATC

levomepromazine; systemic

4.2

307.7

1503

3014

R63.4

ICD-10 Finland

Abnormal weight loss

4.7

307.7

1156

2020

R07.3

ICD-10 Finland

Other chest pain

2.6

307.7

3197

10494

I50.9

ICD-10 Finland

Heart failure, unspecified

3.2

307.7

5642

16433

A29

ICPC

General symptom/complaint other

2.5

307.7

4173

14410

N06DX01

ATC

memantine; oral

3.3

307.7

2850

7488

R51.80

ICD-10 Finland

Headache

7.9

307.7

5226

6260

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.4

307.7

1183

1544

G04CA02

ATC

tamsulosin; oral

1.8

307.7

7042

34432

L28

ICPC

Limited function/disability (L)

3.6

307.7

7411

20397

UKC02

NOMESCO Finland

Cystoscopy

2.2

307.7

5096

20371

I50.0

ICD-10 Finland

Congestive heart failure

3.1

307.7

2825

7866

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

307.7

6738

29341

E87.6

ICD-10 Finland

Hypokalaemia

4.6

307.7

1305

2368

I95.9

ICD-10 Finland

Hypotension, unspecified

6.4

307.7

629

806

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.9

307.7

2737

7989

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

307.7

5765

23127

A10AB05

ATC

insulin aspart; parenteral

2.7

307.7

2437

7603

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

307.7

4015

11591

ZXD05

NOMESCO Finland

Urgent procedure

2.0

307.7

9222

43830

J01DB01

ATC

cefalexin; oral

2.0

307.7

24035

159911

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.1

307.7

3123

6719

A41.9

ICD-10 Finland

Sepsis, unspecified

3.9

307.7

1196

2562

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

307.7

3004

7433

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.8

307.7

924

1581

N06AB06

ATC

sertraline; oral

2.6

307.7

3502

11882

7807A

ICD-9 Finland

General symptoms, Malaise and fatigue

+∞

307.7

407

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

307.7

6058

17878

SPAT1263

SPAT

Sampling

1.8

307.7

12340

66861

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

307.7

2145

5980

N06AX26

ATC

vortioxetine; oral

3.0

307.7

2312

6616

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

307.7

3061

10211

N05BA04

ATC

oxazepam; oral

2.8

307.7

9491

34495

A46

ICD-10 Finland

Erysipelas

2.4

307.7

4611

16805

SPAT1252

SPAT

Overall medication plan or its review

2.7

307.7

2187

6897

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.2

307.7

5967

13484

N02BF02

ATC

pregabalin; oral

2.9

307.6

1635

4746

N05AD01

ATC

haloperidol; systemic

3.6

307.3

1128

2610

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.3

306.8

1303

3315

R51.81

ICD-10 Finland

Facial pain NOS

6.6

306.7

543

670

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.1

305.4

705

1134

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

304.4

2713

10115

G20

ICD-10 Finland

Parkinson disease

3.4

304.0

1179

2830

N04AA02

ATC

biperiden; systemic

5.0

302.2

718

1185

N06AX03

ATC

mianserin; oral

3.0

301.8

1500

4192

E0000UV, ,

ATC

1.6

301.5

11377

66670

N06DA02

ATC

donepezil; oral

2.6

301.0

1933

6196

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

300.1

1383

3698

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.3

299.5

846

1615

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

298.6

2118

7125

N06AX12

ATC

bupropion; oral

2.6

298.5

1939

6250

I49.5

ICD-10 Finland

Sick sinus syndrome

3.4

298.1

1208

2983

B03BA03

ATC

hydroxocobalamin; parenteral

2.7

297.3

1816

5675

M04AA01

ATC

allopurinol; systemic

2.0

297.2

3672

15553

S70.0

ICD-10 Finland

Contusion of hip

3.2

296.6

1270

3247

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.6

295.9

526

652

SPAT1097

SPAT

Recording of ECG

1.9

295.7

4148

18371

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

295.0

1668

5005

A11

ICPC

Chest pain NOS

2.4

294.8

2357

8378

S18

ICPC

Laceration/cut

1.6

294.7

12170

72732

SPAT1260

SPAT

Consultation of another employee

1.8

294.5

4986

23483

M48.0

ICD-10 Finland

Spinal stenosis

2.1

293.7

3427

14211

H02AB09

ATC

hydrocortisone; systemic

4.5

293.6

778

1410

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

293.1

3863

16738

A08

ICPC

Swelling

2.9

292.4

1495

4245

G30.8

ICD-10 Finland

Other Alzheimer disease

4.1

292.4

867

1719

R35

ICD-10 Finland

Polyuria

2.5

291.3

2020

6720

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.5

291.3

771

1396

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.9

289.5

1497

4277

XKD00

NOMESCO Finland

Uroflowmetry

1.9

288.6

4480

20508

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

287.4

3389

14100

SPAT1101

SPAT

Orthostatic test

3.0

287.3

1375

3758

M79.7

ICD-10 Finland

Fibromyalgia

3.7

287.3

1000

2230

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

287.1

3737

16113

R25.1

ICD-10 Finland

Tremor, unspecified

3.6

286.2

1033

2362

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.9

285.4

1483

4248

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

283.0

3571

15223

SPAT1304

SPAT

Counselling and guidance related to ageing

2.4

282.6

2195

7696

SPAT1240

SPAT

Therapeutic discussion

2.2

282.5

2836

11089

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

282.5

1574

4684

A04AA01

ATC

ondansetron; systemic, rectal

2.4

281.7

2155

7503

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

281.2

6664

34577

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.2

281.1

1226

3169

N05AB03

ATC

perphenazine; systemic, rectal

3.4

280.7

1115

2717

I20.09

ICD-10 Finland

Unstable angina

2.7

280.7

1738

5465

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.5

278.6

1073

2562

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

277.5

2004

6792

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

277.2

3693

16041

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

276.7

2519

9460

R31

ICD-10 Finland

Unspecified haematuria

2.1

276.6

3007

12125

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

276.1

1485

4334

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

275.8

11525

68749

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.4

275.7

593

893

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.9

275.6

877

1833

I50

ICD-10 Finland

Heart failure

3.5

275.0

1051

2497

G04BD12

ATC

mirabegron; oral

2.0

274.2

3305

13849

D12

ICPC

Constipation

3.2

273.7

1168

2978

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

273.6

7495

40366

SPAT1139

SPAT

Nutrition survey

3.3

272.5

1107

2736

A10BA02

ATC

metformin; oral

1.6

272.4

7858

42875

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

272.2

2739

10712

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

272.1

2506

9455

H03AA01

ATC

levothyroxine sodium; systemic

1.7

271.9

6313

32531

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.4

270.1

1061

2566

K90

ICPC

Stroke/cerebrovascular accident

3.7

269.0

934

2078

P01

ICPC

Feeling anxious/nervous/tense

2.1

269.0

3110

12827

T90

ICPC

Diabetes non-insulin dependent

1.7

268.0

6433

33432

SPAT1255

SPAT

Intravenous administration of medicine

2.5

267.4

1910

6437

XF402

NOMESCO Finland

ECG with work load test

2.1

267.2

2918

11778

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.5

266.9

718

1317

P03

ICPC

Feeling depressed

2.2

266.9

2624

10164

K07

ICPC

Swollen ankles/oedema

2.9

266.3

1354

3829

K30

ICD-10 Finland

Functional dyspepsia

2.1

265.8

3026

12407

N19

ICD-10 Finland

Unspecified kidney failure

3.2

265.6

1155

2979

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.9

265.5

859

1817

N05AN01

ATC

lithium; oral

4.1

264.0

781

1545

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

263.9

1924

6546

U07

ICPC

Urine symptom/complaint other

2.3

263.6

2152

7707

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.1

263.5

1241

3358

N01

ICPC

Headache

2.1

263.3

2803

11200

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.0

262.1

828

1721

K59.1

ICD-10 Finland

Functional diarrhoea

2.7

260.4

1599

5003

D01

ICPC

Abdominal pain/cramps general

2.0

259.6

3175

13358

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.3

259.0

1091

2758

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

259.0

1449

4318

N05BE01

ATC

buspirone; oral

3.6

258.9

920

2080

R4120

NOMESCO Finland

Occupational therapy

2.5

257.8

1837

6182

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.6

257.7

668

1188

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.7

257.7

660

1162

J01CA08

ATC

pivmecillinam; oral

1.6

257.1

10575

62583

N02BF01

ATC

gabapentin; oral

2.3

257.0

2123

7640

R54

ICD-10 Finland

Senility

30.8

256.8

198

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

256.4

9491

54831

U05

ICPC

Urination problems other

2.7

256.3

1536

4745

N04BC05

ATC

pramipexole; oral

2.3

255.6

2172

7913

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.8

255.5

867

1898

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.7

254.2

518

740

M79.1

ICD-10 Finland

Myalgia

1.9

253.4

3698

16532

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

253.3

10651

63287

205

Kela drug reimbursment

Chronic hypertension

1.6

252.3

7572

41582

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

251.9

4853

23660

XA800

NOMESCO Finland

Neuropsychological investigation

3.1

251.8

1182

3191

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

251.7

1455

4410

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

251.6

10842

64746

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

251.2

2816

11466

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

250.6

2754

11130

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

250.5

19076

128529

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

249.8

5132

25483

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

249.0

13688

86065

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.3

248.7

1030

2576

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

247.9

3360

14644

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.7

246.9

843

1853

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

3.9

246.4

800

1696

P01AB01

ATC

metronidazole; oral, rectal

1.5

246.2

10319

61168

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

246.2

4256

20071

SPAT1279

SPAT

Preparation of immediate hospitalisation

6.7

245.6

430

524

Z2445

NOMESCO Finland

Psychologist

3.1

245.2

1106

2915

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.6

244.6

633

1124

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.0

243.2

749

1527

N87

ICPC

Parkinsonism

4.9

243.1

584

973

P70

ICPC

Dementia

3.8

242.8

795

1696

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.4

241.8

1772

6037

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

241.1

3827

17564

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.3

239.9

667

1256

79199

ICD-8 Finland

Headache

+∞

239.5

250

C10AA05

ATC

atorvastatin; oral

1.5

239.5

10936

65939

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.9

239.4

779

1654

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

238.9

1253

3602

F01.9

ICD-10 Finland

Vascular dementia, unspecified

4.8

238.9

586

994

S00.0

ICD-10 Finland

Superficial injury of scalp

3.9

238.0

762

1599

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.3

237.9

1944

6956

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

237.6

7474

41409

WW500

NOMESCO Finland

Blood transfusion

3.0

237.5

1123

3043

J01MA14

ATC

moxifloxacin; systemic

2.2

237.4

2339

9051

P99

ICPC

Psychological disorders other

3.6

236.6

868

2005

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.2

236.3

1014

2592

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

235.5

2394

9379

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

8.3

235.4

343

335

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.7

233.6

818

1830

A10BH05

ATC

linagliptin; oral

2.6

233.3

1522

4903

J01AA02

ATC

doxycycline; systemic

1.5

233.3

21164

146792

A99

ICPC

Disease/condition unspecnature/site

2.1

233.2

2585

10468

M05BX04

ATC

denosumab; parenteral

2.5

233.0

1621

5387

L03

ICPC

Low back symptom/complaint

1.6

232.3

7038

38605

S22.3

ICD-10 Finland

Fracture of rib

2.3

232.1

1926

6936

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.6

231.4

840

1926

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

230.7

2104

7887

F10.24

ICD-10 Finland

Alcohol depence active use

5.6

230.5

476

689

U02

ICPC

Urinary frequency/urgency

1.8

230.2

3764

17418

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

230.1

2518

10145

S72.0

ICD-10 Finland

Fracture of neck of femur

2.8

229.9

1274

3773

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

229.9

1057

2817

N05AH02

ATC

clozapine; systemic

4.7

229.0

574

992

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.8

228.9

1279

3805

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

228.5

2272

8819

N06AA12

ATC

doxepin; systemic

2.6

228.5

1486

4779

H02AB07

ATC

prednisone; oral

1.9

228.4

3650

16766

G47.3

ICD-10 Finland

Sleep apnoea

1.7

227.9

5621

29255

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.2

226.6

1000

2600

K08.3

ICD-10 Finland

Retained dental root

2.2

226.3

2102

7937

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

226.2

1724

5976

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.1

226.1

669

1323

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

225.3

4386

21381

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.3

224.3

637

1220

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.0

224.1

525

855

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.1

223.9

1031

2750

ZY000

NOMESCO Finland

Hospital inpatient

5.7

223.0

454

648

E87.5

ICD-10 Finland

Hyperkalaemia

4.4

221.8

606

1125

N05CF02

ATC

zolpidem; oral

1.7

221.3

4420

21696

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.9

220.3

701

1464

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.1

220.2

664

1332

K92.0

ICD-10 Finland

Haematemesis

3.7

220.1

774

1736

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

219.6

3957

18845

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.0

219.0

1088

3032

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.3

218.5

894

2217

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

218.4

4980

25351

P15

ICPC

Chronic alcohol abuse

3.5

218.0

811

1890

K78

ICPC

Atrial fibrillation/flutter

2.2

217.7

2164

8393

C01AA05

ATC

digoxin; systemic

2.1

217.7

2457

10007

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.2

217.0

956

2482

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.4

215.3

590

1098

A10AC01

ATC

insulin (human); parenteral

2.2

215.3

2102

8094

ZXA10

NOMESCO Finland

Bilateral

1.7

215.1

4959

25308

P76

ICPC

Depressive disorder

2.4

214.4

1688

5934

D11

ICPC

Diarrhoea

1.9

214.4

3018

13286

F21, ,

ICPC

7.3

214.1

345

382

M05BA04

ATC

alendronic acid; oral

2.1

213.8

2293

9158

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.1

213.3

634

1258

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.0

212.7

664

1367

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.2

212.7

625

1229

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

212.0

10363

62946

ZXD35

NOMESCO Finland

Usual procedure

3.0

211.9

1007

2735

G93.3

ICD-10 Finland

Postviral fatigue syndrome

11.5

211.7

247

174

A07AA09

ATC

vancomycin; oral

5.3

211.7

470

729

WVA20

NOMESCO Finland

Medicine administration

3.5

211.3

794

1863

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

211.1

2460

10133

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.3

209.0

596

1145

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

208.6

1105

3191

J01FA06

ATC

roxithromycin; oral

1.5

207.6

10180

61803

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.4

207.1

566

1051

Z00.0

ICD-10 Finland

General medical examination

1.7

206.9

5116

26568

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

206.4

1317

4192

N29

ICPC

Neurological sympt/complt other

4.0

206.2

631

1280

J01DA01

ATC

[U] cefalexin

1.5

206.1

16531

110354

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.3

206.1

453

696

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

205.6

1784

6540

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

204.5

1489

5050

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

204.4

4533

22861

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.0

204.3

974

2650

N03AX11

ATC

topiramate; oral

4.0

203.4

626

1275

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

203.0

1554

5392

F34.1

ICD-10 Finland

Dysthymia

2.9

202.9

1013

2830

A41.8

ICD-10 Finland

Other specified sepsis

4.4

201.2

554

1035

SPAT1251

SPAT

Organisation of medication

2.8

200.7

1067

3087

SPAT1211

SPAT

Application of soft bandage

2.0

200.4

2374

9830

H02AA02

ATC

fludrocortisone; oral

6.9

200.3

340

400

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.7

200.1

1149

3465

SPAT1104

SPAT

Monitoring of emergency patient

2.2

200.0

1792

6656

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

199.6

2806

12331

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

198.2

2887

12835

WYA20

NOMESCO Finland

Home visit

4.2

198.1

582

1144

X58

ICD-10 Finland

Exposure to other specified factors

1.8

196.7

3481

16448

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.6

195.7

708

1619

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

195.6

2520

10746

A10BH01

ATC

sitagliptin; oral

2.0

195.5

2565

11008

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

195.1

2037

8043

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.2

194.9

441

696

SPAT1125

SPAT

Stoma care and guidance

4.3

193.4

550

1054

C09AA02

ATC

enalapril; systemic

1.6

192.9

5220

27679

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

192.7

1775

6666

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

192.4

1529

5392

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

10.3

191.1

239

188

R41.3

ICD-10 Finland

Other amnesia

3.0

191.0

902

2440

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.4

190.1

517

956

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.0

189.6

447

732

Z29

ICPC

Social problem NOS

3.7

189.6

657

1458

A10BB12

ATC

glimepiride; oral

2.1

189.5

1983

7833

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

189.5

785

1961

A07AA02

ATC

nystatin; oral

2.3

189.4

1559

5583

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

189.2

2550

11039

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

188.7

3705

18030

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

187.4

5332

28596

N18

ICPC

Paralysis/weakness

3.8

187.1

611

1300

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.5

187.1

1335

4482

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

186.4

1694

6325

M03BX01

ATC

baclofen; systemic

4.2

185.5

529

1016

P06

ICPC

Sleep disturbance

1.8

185.5

2935

13386

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.5

184.7

701

1655

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

182.2

10739

67118

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

181.5

1831

7128

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

2.8

181.1

1011

3002

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

180.3

1498

5383

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

180.3

9413

57458

B03XA02

ATC

darbepoetin alfa; parenteral

3.9

180.1

581

1225

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

179.6

1085

3357

S29

ICPC

Skin symptom/complaint other

1.6

179.4

4884

25883

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.3

179.2

720

1764

XW000

NOMESCO Finland

Bone marrow biopsy

2.8

178.9

998

2962

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

178.9

1188

3853

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.9

178.5

578

1222

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.0

178.1

833

2240

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.1

177.3

536

1077

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

176.7

1260

4227

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.0

176.3

847

2313

N07BB01

ATC

disulfiram; oral

2.7

175.0

1042

3199

P74

ICPC

Anxiety disorder/anxiety state

2.6

174.6

1087

3414

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

174.5

11852

75842

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

174.4

3167

15045

N28

ICPC

Limited function/disability (N)

4.1

173.9

524

1050

R4190

NOMESCO Finland

Nutritional therapy

2.7

173.8

997

3002

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

173.4

1151

3731

R32

ICD-10 Finland

Unspecified urinary incontinence

3.0

173.1

813

2191

R06.4

ICD-10 Finland

Hyperventilation

4.3

173.1

483

912

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.8

173.0

948

2786

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

3.1

172.9

766

1994

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

4.5

172.9

464

849

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

172.4

1966

8013

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.6

172.3

613

1385

L01

ICPC

Neck symptom/complaint

1.7

171.9

3770

18882

F61.0

ICD-10 Finland

Mixed personality disorders

4.2

170.9

487

935

N18.8

ICD-10 Finland

Other chronic renal failure

3.2

170.5

719

1816

C08CA13

ATC

lercanidipine; oral

1.7

170.2

3621

17982

M10.9

ICD-10 Finland

Gout, unspecified

2.1

170.2

1765

6941

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

169.7

4919

26430

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

169.2

1562

5864

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.4

169.1

455

834

N05AA01

ATC

chlorpromazine; systemic, rectal

4.7

169.1

429

749

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.9

168.7

404

671

A03

ICPC

Fever

1.7

168.6

4016

20548

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

168.5

176

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

168.1

4973

26840

SPAT1360

SPAT

Extensive global examination

2.0

168.0

1898

7707

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

168.0

4022

20605

J01CA04

ATC

amoxicillin; systemic

1.5

167.6

22210

159420

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.5

167.6

445

807

R04.0

ICD-10 Finland

Epistaxis

2.0

167.0

1967

8110

A01AB09

ATC

miconazole; local oral

1.9

166.7

2263

9803

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.5

166.7

436

781

EBA00

NOMESCO Finland

Extraction of tooth

1.4

166.6

8982

54969

Y94.0

ICD-10 Finland

Accident at home

3.6

166.3

589

1327

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

166.1

2539

11435

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.8

166.0

550

1182

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.3

165.7

360

547

R06AE07

ATC

cetirizine; oral

1.4

165.7

11040

70208

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

165.6

7029

41040

TK800

NOMESCO Finland

Hemodialysis

3.7

165.0

575

1281

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.1

164.9

738

1933

P72

ICPC

Schizophrenia

3.9

164.9

532

1122

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

164.4

2573

11673

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.3

164.3

305

396

N06AX05

ATC

trazodone; oral

3.2

164.0

692

1748

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

163.7

823

2306

K77

ICPC

Heart failure

3.4

163.7

649

1576

R05

ICD-10 Finland

Cough

1.6

163.6

5277

29036

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.9

163.6

840

2382

A10AE05

ATC

insulin detemir; parenteral

2.3

163.4

1423

5213

G04BD08

ATC

solifenacin; oral

2.1

163.0

1750

6970

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

162.8

3012

14370

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.6

162.6

334

481

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.5

162.2

1112

3660

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.8

162.1

538

1158

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

161.9

2447

10977

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

161.5

1843

7509

RS221, ,

NOMESCO Finland

4.3

161.4

448

842

M25.5

ICD-10 Finland

Pain in joint

1.5

161.2

7551

44924

A03FA02

ATC

cisapride; oral, rectal

2.0

161.1

1983

8302

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

161.0

8856

54324

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

160.9

1213

4172

N05BA02

ATC

chlordiazepoxide; systemic

3.3

160.8

666

1663

L29

ICPC

Musculoskeletal sympt/complt other

1.9

160.7

2158

9311

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.3

160.4

1274

4485

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.5

160.4

603

1414

SPAT1310

SPAT

Counselling related to known health issue

1.5

160.1

8095

48865

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

159.7

1434

5320

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

6.9

159.2

271

320

WX882

NOMESCO Finland

High dependency care

3.0

159.2

764

2085

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.6

159.1

985

3084

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

158.8

860

2511

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.6

158.3

568

1291

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.5

158.2

421

765

Z00.8

ICD-10 Finland

Other general examinations

2.0

158.0

2012

8522

Angiography of the heart and coronary arteries

2.1

157.3

1664

6588

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.5

157.2

333

494

M54.2

ICD-10 Finland

Cervicalgia

2.0

157.2

1863

7693

P18

ICPC

Medication abuse

8.5

157.0

225

215

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

10.3

156.9

196

154

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

156.1

1083

3584

G40

ICD-10 Finland

Epilepsy

6.8

156.1

267

317

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.4

155.8

422

778

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.0

155.8

213

191

A27

ICPC

Fear of other disease NOS

2.3

155.6

1280

4575

B34.9

ICD-10 Finland

Viral infection, unspecified

3.0

155.4

734

1984

R03DC03

ATC

montelukast; oral

1.6

155.2

3924

20349

A05

ICPC

Feeling ill

2.1

155.0

1565

6085

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

154.9

1381

5107

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.8

154.7

863

2560

183

Kela drug reimbursment

Lamotrigin and topiramate

7.3

153.8

248

275

C09CA01

ATC

losartan; oral

1.5

153.7

6362

36865

M02AA07

ATC

piroxicam; topical

1.4

153.7

9046

56071

L14

ICPC

Leg/thigh symptom/complaint

2.0

153.2

1991

8489

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.0

152.8

356

577

RS222, ,

NOMESCO Finland

4.8

152.4

377

644

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.6

152.1

533

1192

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.8

151.6

301

419

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.6

151.6

977

3120

K29

ICPC

Cardiovascular sympt/complt other

2.4

151.5

1168

4057

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.2

151.5

650

1659

N06AX22

ATC

agomelatine; oral

3.3

151.0

607

1487

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.2

150.6

428

820

N06AB05

ATC

paroxetine; oral

2.2

150.5

1473

5657

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

149.6

2019

8719

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

149.5

2627

12330

H02AB04

ATC

methylprednisolone; systemic

1.7

149.0

3500

17798

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.7

148.8

894

2756

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

148.4

4946

27347

B81

ICPC

Anaemia vit B12/folate deficiency

2.5

148.3

1023

3375

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

147.8

2819

13547

C03AA03

ATC

hydrochlorothiazide; oral

1.8

147.6

2364

10787

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

147.0

794

2314

R05

ICPC

Cough

1.5

147.0

5871

33728

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

146.9

604

1501

J46

ICD-10 Finland

Status asthmaticus

2.9

146.9

751

2124

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.3

146.8

607

1514

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

146.7

1507

5896

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

146.3

5550

31542

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

3.3

146.1

595

1470

W06

ICD-10 Finland

Fall involving bed

5.7

146.0

295

418

G04BD07

ATC

tolterodine; oral

2.2

145.8

1309

4854

N06AG02

ATC

moclobemide; oral

2.4

145.7

1119

3879

D06

ICPC

Abdominal pain localized other

1.9

145.6

2124

9408

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

145.5

1030

3440

N03AX18

ATC

lacosamide; systemic

8.2

145.3

214

212

Z43.5

ICD-10 Finland

Attention to cystostomy

7.2

145.0

237

267

D07AC01

ATC

betamethasone; topical

1.4

144.6

9015

56309

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.2

144.5

320

495

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

144.4

463

972

OAB43, ,

SPAT

0.6

144.4

3099

38613

Z08

ICPC

Social welfare problem

4.4

144.3

397

741

G04CB01

ATC

finasteride; oral

1.7

144.2

2992

14714

D64.8

ICD-10 Finland

Other specified anaemias

3.5

144.0

531

1229

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

4.2

144.0

416

807

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

143.9

2093

9259

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.4

143.8

391

723

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.6

143.8

367

644

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

143.7

683

1853

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

143.6

2513

11774

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

143.4

2697

12903

F06.7

ICD-10 Finland

Mild cognitive disorder

2.7

143.2

811

2424

I20.00

ICD-10 Finland

Unstable angina

2.7

143.1

832

2521

F45.0

ICD-10 Finland

Somatization disorder

10.1

143.1

181

145

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

143.0

2050

9027

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

142.9

677

1833

H53.2

ICD-10 Finland

Diplopia

2.7

142.7

824

2488

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

142.7

3262

16461

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

142.6

699

1930

A11CC03

ATC

alfacalcidol; systemic

3.1

142.4

630

1638

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.9

141.9

450

937

R04.2

ICD-10 Finland

Haemoptysis

2.6

141.9

903

2865

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.6

141.8

295

430

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

141.5

872

2722

SPAT1050

SPAT

Extensive neurological examination

3.2

141.5

608

1553

SPAT1127

SPAT

Enema

5.7

141.2

288

412

R96

ICPC

Asthma

1.8

140.5

2325

10708

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

140.2

2077

9241

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

140.0

6703

39858

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.5

139.6

939

3060

SPAT1138

SPAT

Guidance concerning bowel function

3.8

138.9

464

1003

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

138.9

1984

8723

F32

ICD-10 Finland

Depressive episode

2.2

138.9

1334

5082

N88

ICPC

Epilepsy

9.4

138.7

184

158

A02BA04

ATC

nizatidine; systemic

1.9

138.6

1951

8537

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

138.5

722

2064

C08CA02

ATC

felodipine; oral

1.8

138.5

2444

11474

U28

ICPC

Limited function/disability (U)

4.7

137.4

345

597

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

137.3

1056

3662

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

137.2

1524

6138

M01AH02

ATC

rofecoxib; oral

1.7

137.2

3092

15534

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

136.9

1505

6039

NF3AA

NOMESCO Finland

Femur X-ray examination

3.2

136.8

580

1469

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

136.3

2610

12543

A12BA01

ATC

potassium chloride; oral

2.2

136.1

1211

4471

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

136.1

1192

4372

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

135.8

1041

3605

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

135.7

1721

7268

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.8

135.3

447

959

WX872

NOMESCO Finland

Intensive care

2.2

135.2

1260

4741

U08

ICPC

Urinary retention

3.2

135.1

585

1501

N05AF05

ATC

zuclopenthixol; systemic

4.9

135.1

325

542

N06AA06

ATC

trimipramine; systemic

3.0

135.0

645

1755

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

134.9

1525

6181

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

134.9

1682

7062

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.0

134.7

637

1723

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.2

134.6

1260

4750

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

134.5

989

3360

S09.9

ICD-10 Finland

Unspecified injury of head

3.9

134.5

424

879

C02AC05

ATC

moxonidine; oral

2.3

134.4

1160

4229

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.2

133.8

386

748

Z50.1

ICD-10 Finland

Other physical therapy

2.1

133.8

1336

5167

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.5

132.7

937

3124

R03BA02

ATC

budesonide; inhalant

1.5

132.7

4363

23988

IGV01

NOMESCO Finland

Psychiatric network contact

5.1

132.5

304

486

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

132.3

1459

5859

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.5

132.1

497

1166

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.1

132.1

1420

5649

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

132.1

1743

7461

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

131.9

580

1502

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

4.2

131.4

376

724

F05.8

ICD-10 Finland

Other delirium

5.7

131.3

266

378

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

131.0

1317

5106

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.4

130.9

516

1248

A97

ICPC

No disease

1.5

130.7

4514

25080

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

130.4

4705

26383

L04

ICPC

Chest symptom/complaint

2.0

130.3

1502

6130

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.5

130.3

477

1099

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.0

130.1

304

494

R40.2

ICD-10 Finland

Coma, unspecified

5.9

130.1

257

356

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

130.0

1201

4502

R03BA05

ATC

fluticasone; inhalant

1.5

129.7

4429

24541

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.2

129.3

371

716

J01MA06

ATC

norfloxacin; oral

1.6

129.1

3174

16290

U01

ICPC

Dysuria/painful urination

1.9

128.5

1897

8423

PA6AD

NOMESCO Finland

CT of neck arteries

2.7

128.5

730

2185

H57.1

ICD-10 Finland

Ocular pain

2.5

128.4

867

2830

R40.0

ICD-10 Finland

Somnolence

9.5

128.1

169

144

N17.8

ICD-10 Finland

Other acute renal failure

4.2

127.5

371

724

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

126.9

11447

75520

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.2

126.8

1233

4717

E000001, ,

ATC

1.5

126.8

4870

27651

H26.4

ICD-10 Finland

After-cataract

1.7

126.6

2505

12137

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.1

126.6

566

1481

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

126.4

527

1321

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.5

126.3

200

217

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

126.3

1370

5467

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

126.2

1197

4534

C09CA06

ATC

candesartan; oral

1.5

126.1

5635

32969

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.1

126.0

570

1502

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

125.7

1019

3616

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.5

125.5

858

2817

R25.2

ICD-10 Finland

Cramp and spasm

2.9

125.5

627

1750

UJD02

NOMESCO Finland

Gastroscopy

2.2

125.4

1175

4429

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

125.4

850

2780

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.1

125.0

564

1484

R63.1

ICD-10 Finland

Polydipsia

21.0

124.8

109

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

124.8

1055

3811

SPAT1312

SPAT

General health counselling

1.4

124.8

7926

49391

G43.3

ICD-10 Finland

Complicated migraine

4.0

124.7

380

768

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.2

124.4

527

1334

K85

ICPC

Elevated blood pressure

1.6

124.3

3887

21108

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.5

124.0

328

593

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

124.0

9200

58805

R07.2

ICD-10 Finland

Precordial pain

3.1

123.8

568

1509

J45

ICD-10 Finland

Asthma

1.7

123.8

2456

11905

N30

ICD-10 Finland

Cystitis

1.8

123.7

1948

8825

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.9

123.6

1782

7850

K91

ICPC

Cerebrovascular disease

3.8

123.4

399

843

L04AA06

ATC

mycophenolic acid; systemic

3.5

123.1

456

1059

M01AH01

ATC

celecoxib; oral

1.5

122.9

4225

23419

U29

ICPC

Urinary symptom/complaint other

2.6

122.9

771

2428

C08DB01

ATC

diltiazem; oral

2.0

122.7

1409

5740

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

122.7

1297

5125

P28

ICPC

Limited function/disability (P)

5.1

122.6

281

449

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.4

122.5

468

1109

R03AC03

ATC

terbutaline; inhalant

1.6

122.4

3317

17420

SPAT1325

SPAT

Vaccination

1.4

122.4

8607

54512

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.6

122.4

754

2353

K28

ICPC

Limited function/disability (K)

3.0

121.9

590

1617

Z03

ICPC

Housing/neighbourhood problem

5.9

121.5

238

327

S20.2

ICD-10 Finland

Contusion of thorax

2.1

121.0

1266

4982

WZC30

NOMESCO Finland

Teaching

1.6

121.0

3557

19037

EBA30

NOMESCO Finland

Extraction of root of tooth

2.0

121.0

1383

5625

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.3

120.9

194

214

XG466

NOMESCO Finland

Sleep oxymetry

2.6

120.8

781

2496

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

120.5

1425

5866

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

120.5

2118

9916

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

120.3

904

3101

B01AC07

ATC

dipyridamole; systemic

2.1

120.3

1198

4626

R60.1

ICD-10 Finland

Generalized oedema

7.6

120.2

188

201

R12

ICD-10 Finland

Heartburn

1.8

119.8

1915

8712

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.7

119.7

671

1994

F05.1

ICD-10 Finland

Delirium superimposed on dementia

5.5

119.7

251

369

D02

ICPC

Abdominal pain epigastric

2.0

119.2

1431

5922

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

119.1

1058

3902

J01CF05

ATC

flucloxacillin; systemic

2.0

118.7

1431

5931

U13

ICPC

Bladder symptom/complaint other

2.5

118.6

782

2523

B01AB10

ATC

tinzaparin; parenteral

1.7

118.5

2315

11167

J02AC01

ATC

fluconazole; systemic

1.4

118.5

9280

59721

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

118.4

2077

9715

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.5

118.4

805

2636

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

118.4

1429

5926

S80.0

ICD-10 Finland

Contusion of knee

1.9

118.2

1695

7451

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.2

118.2

336

644

L12

ICPC

Hand/finger symptom/complaint

1.5

117.9

3754

20447

L02

ICPC

Back symptom/complaint

1.7

117.7

2302

11109

C07AG02

ATC

carvedilol; oral

2.0

117.2

1469

6172

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

117.2

7168

44294

I50.1

ICD-10 Finland

Left ventricular failure

2.1

117.1

1280

5120

N06DA04

ATC

galantamine; oral

2.7

117.0

671

2018

D07AA02

ATC

hydrocortisone; topical

1.6

116.5

3350

17826

R10.0

ICD-10 Finland

Acute abdomen

2.5

116.4

804

2652

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.5

116.3

431

1001

U71

ICPC

Cystitis/urinary infection other

1.9

116.3

1589

6874

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.8

116.3

383

820

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

116.2

1769

7924

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.2

115.8

1033

3815

K99

ICPC

Cardiovascular disease other

2.6

115.6

697

2151

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.6

115.4

698

2158

L76

ICPC

Fracture: other

2.5

115.3

756

2433

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.6

115.1

402

897

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

115.1

1300

5263

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.4

114.8

859

2940

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

114.7

2293

11129

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

114.6

1195

4695

K80

ICPC

Cardiac arrhythmia NOS

1.8

114.5

1954

9063

I95.2

ICD-10 Finland

Hypotension due to drugs

5.4

114.3

244

365

S00.8

ICD-10 Finland

Superficial injury of other parts of head

3.2

114.1

483

1222

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.8

114.0

632

1867

R4130

NOMESCO Finland

Speech therapy

2.8

113.9

634

1877

X57

ICD-10 Finland

Unspecified privation

2.9

113.6

589

1678

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

113.5

1309

5339

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

5.8

113.0

226

317

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.9

112.9

570

1600

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

112.9

1068

4040

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.1

112.8

519

1381

M01AX17

ATC

nimesulide; oral

1.4

112.7

5652

33693

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

112.4

6143

37188

F32.8

ICD-10 Finland

Other depressive episodes

3.5

112.3

424

997

B82

ICPC

Anaemia other/unspecified

2.6

112.3

714

2263

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

5.7

112.3

227

322

N05AC02

ATC

thioridazine; oral

3.0

112.2

524

1407

C08DA01

ATC

verapamil; systemic

2.2

111.9

1031

3859

F22.0

ICD-10 Finland

Delusional disorder

3.5

111.8

414

961

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

111.7

6252

37995

D21

ICPC

Swallowing problem

3.5

111.7

412

954

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

10.4

111.5

138

107

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.5

111.3

767

2527

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.2

111.3

1035

3888

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.2

111.0

246

381

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

110.8

1861

8589

XF606

NOMESCO Finland

Ortostatic test

6.2

110.5

206

269

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

110.4

821

2802

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

110.0

13489

92402

C08CA05

ATC

nifedipine; systemic

1.9

109.7

1565

6864

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

109.7

507

1353

A13

ICPC

Concern/fear medical treatment

3.1

109.5

485

1262

E66.8

ICD-10 Finland

Other obesity

2.0

109.4

1205

4832

N99

ICPC

Neurological disease other

3.9

109.0

349

732

A06AC51

ATC

ispaghula, combinations; oral

2.1

108.9

1171

4653

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.4

108.9

783

2632

F31

ICD-10 Finland

Bipolar affective disorder

4.0

108.8

334

679

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.1

108.8

320

630

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

108.7

1046

3983

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.4

108.7

773

2585

A10AD05

ATC

insulin aspart; parenteral

3.1

108.7

501

1335

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.3

108.6

884

3140

R30.0

ICD-10 Finland

Dysuria

2.2

108.6

1006

3773

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.9

108.3

348

732

L05

ICPC

Flank/axilla symptom/complaint

1.9

108.2

1393

5903

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

10.8

108.2

131

K04

ICPC

Palpitations/awareness of heart

2.0

108.2

1285

5295

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

108.2

1464

6310

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.3

108.0

301

568

SPAT1153

SPAT

Removal of sutures

1.4

107.8

7516

47331

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.8

107.8

601

1781

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

107.7

5581

33429

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

7.6

107.7

168

179

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

107.7

765

2557

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.9

107.4

554

1574

M54.8

ICD-10 Finland

Other dorsalgia

2.1

107.3

1047

4009

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

5.0

106.8

249

404

127

Kela drug reimbursment

Transplant complication

3.8

106.7

348

740

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.9

106.6

340

711

N06AA10

ATC

nortriptyline; systemic

3.1

106.5

469

1216

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

106.5

2886

15126

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.0

106.0

516

1419

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

105.7

2422

12177

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

105.7

838

2943

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

105.7

565

1637

R06.5

ICD-10 Finland

Mouth breathing

1.7

105.7

2021

9681

XCK00

NOMESCO Finland

Perimetry

1.9

105.6

1533

6759

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

105.6

389

900

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

105.4

1395

5968

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

105.2

9280

60537

WX212

NOMESCO Finland

Femoral plexus blockade

2.7

104.7

601

1808

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

104.4

5340

31888

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.6

104.3

675

2158

M54

ICD-10 Finland

Dorsalgia

1.6

104.3

2799

14633

N04BD01

ATC

selegiline; oral

3.2

104.1

434

1088

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.9

104.0

327

677

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

103.8

1668

7592

V03AE01

ATC

polystyrene sulfonate; oral

3.7

103.5

346

749

N06BA07

ATC

modafinil; oral

8.0

103.3

154

155

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

9.0

102.8

140

125

S21

ICPC

Skin texture symptom/complaint

1.5

102.6

3355

18341

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.9

102.4

501

1382

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.7

102.3

177

213

N05CD02

ATC

nitrazepam; oral

3.0

102.0

479

1290

D10

ICPC

Vomiting

1.9

102.0

1299

5483

AS4

Physiological pacemaker insertion DDD (R)

3.6

101.9

359

806

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

101.7

1279

5375

N18.0

ICD-10 Finland

End-stage renal disease

4.1

101.7

304

606

WX402

NOMESCO Finland

General anaesthesia

1.4

101.6

4824

28404

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.3

101.6

411

1011

Z72.1

ICD-10 Finland

Alcohol use

3.8

101.3

336

723

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.5

101.3

373

863

I95.8

ICD-10 Finland

Other hypotension

6.9

101.2

170

198

K02.1

ICD-10 Finland

Caries of dentine

1.3

101.1

14444

100554

A06

ICPC

Fainting/syncope

3.7

101.0

342

747

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.8

101.0

538

1556

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

100.6

1024

3984

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.0

100.5

488

1340

3AC01, ,

NOMESCO Finland

4.3

100.4

283

539

R29

ICPC

Respiratory symptom/complaint other

1.8

100.3

1539

6904

R39.1

ICD-10 Finland

Other difficulties with micturition

2.4

100.2

765

2642

A02BC04

ATC

rabeprazole; oral

1.7

100.1

1935

9291

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.8

99.9

324

686

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

99.5

1909

9148

C10AC01

ATC

colestyramine; oral

2.5

99.3

661

2142

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

4.1

99.1

297

593

M54.3

ICD-10 Finland

Sciatica

1.9

98.9

1329

5711

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.2

98.9

883

3261

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.8

98.8

522

1503

C10AA03

ATC

pravastatin; oral

1.8

98.8

1714

7980

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

98.7

824

2959

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

98.6

461

1239

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

98.5

1794

8471

G40.89

ICD-10 Finland

Other epilepsy

8.4

98.3

141

135

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

98.3

18123

130254

N05AL01

ATC

sulpiride; systemic

3.3

98.3

398

980

G30

ICD-10 Finland

Alzheimer disease

3.6

97.7

350

795

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

97.6

2589

13484

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

97.5

2641

13824

A12AA04

ATC

calcium carbonate; oral

3.3

97.5

396

977

G50.1

ICD-10 Finland

Atypical facial pain

3.3

97.3

389

950

R81

ICPC

Pneumonia

2.2

97.3

841

3065

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.0

97.2

449

1198

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

97.2

758

2643

P16

ICPC

Acute alcohol abuse

3.3

97.1

386

939

M03BX02

ATC

tizanidine; oral

1.3

97.1

14975

105064

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

97.1

1256

5329

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.6

97.1

610

1922

RS220, ,

NOMESCO Finland

3.7

97.0

330

723

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.5

97.0

258

469

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

96.8

1095

4432

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.5

96.5

152

164

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.4

96.5

381

923

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

96.4

5300

31999

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

96.4

4238

24575

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

96.3

1487

6682

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

96.1

2492

12908

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.4

96.0

378

914

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

95.9

2371

12138

SPAT1244

SPAT

Occupational therapy

3.9

95.9

302

626

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.1

95.9

429

1123

A01AB04

ATC

amphotericin B; local oral

2.0

95.9

1119

4580

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.5

95.7

643

2093

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

95.3

859

3184

NHQ40

NOMESCO Finland

Amputation of toe

3.1

95.1

436

1158

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.7

95.0

563

1722

L86

ICPC

Back syndrome with radiating pain

1.9

94.9

1353

5927

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.9

94.9

143

146

SPAT1281

SPAT

Other administrative function

1.7

94.6

1870

9031

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

6.5

94.5

169

211

-69

ICPC

Other reason for encounter NEC

2.1

94.3

932

3584

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.5

94.3

246

440

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.0

94.3

157

181

S76

ICPC

Skin infection other

1.9

94.2

1210

5120

R63.0

ICD-10 Finland

Anorexia

8.0

94.1

141

143

G72.9

ICD-10 Finland

Myopathy, unspecified

4.6

94.1

242

428

N05BA09

ATC

clobazam; oral

7.0

94.1

156

179

H02AB02

ATC

dexamethasone; systemic

1.6

94.0

2388

12306

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

93.9

686

2322

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.3

93.8

786

2827

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

93.7

1707

8057

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.1

93.7

430

1143

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

93.5

1938

9480

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.7

93.4

520

1540

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

93.3

1059

4291

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

93.3

1212

5149

D07AB08

ATC

desonide; topical

1.6

93.3

2534

13267

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

41.6

93.2

AA400

NOMESCO Finland

Electroconvulsive therapy

4.7

93.1

235

409

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.5

93.0

649

2151

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

92.9

1048

4237

C10AA04

ATC

fluvastatin; oral

1.7

92.7

2042

10150

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

92.5

650

2161

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

92.3

2935

15923

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.1

92.3

956

3744

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

92.1

2537

13324

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.3

91.5

374

926

XA400

NOMESCO Finland

EEG

6.3

91.5

168

216

R06.2

ICD-10 Finland

Wheezing

2.0

91.5

1026

4139

M01AB55

ATC

diclofenac, combinations; oral

1.8

91.4

1533

7063

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.6

91.3

558

1734

S28

ICPC

Limited function/disability (S)

5.0

91.3

211

340

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

4.4

91.2

248

459

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

91.0

303

654

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

91.0

1257

5450

L13

ICPC

Hip symptom/complaint

1.4

91.0

4123

24020

M02AA10

ATC

ketoprofen; topical

1.5

90.9

3648

20764

WW200

NOMESCO Finland

Immunization

2.5

90.6

624

2055

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.5

90.4

331

763

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

90.2

5394

32983

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

90.1

1138

4788

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.0

90.0

174

236

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.5

90.0

598

1936

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.3

89.8

355

861

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

89.6

672

2302

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.3

89.6

713

2508

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

89.5

219

371

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

5.8

89.4

178

249

L16

ICPC

Ankle symptom/complaint

1.6

89.2

2542

13452

B01AB04

ATC

dalteparin; parenteral

1.9

89.0

1207

5201

WX722

NOMESCO Finland

PEEP

2.0

88.6

1068

4420

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

88.4

1361

6107

R15

ICD-10 Finland

Faecal incontinence

2.4

88.2

655

2234

R03BA01

ATC

beclometasone; inhalant

1.5

88.2

3231

18051

WX320

NOMESCO Finland

Spinalanesthesy

1.4

87.8

5726

35485

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.4

87.8

239

443

RD210, ,

NOMESCO Finland

3.0

87.2

418

1140

R44.3

ICD-10 Finland

Hallucinations, unspecified

5.8

87.1

174

244

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.8

87.1

214

364

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

7.1

86.5

142

161

R01AD09

ATC

mometasone; nasal

1.3

86.3

10704

72636

S22

ICPC

Nail symptom/complaint

1.8

86.3

1476

6837

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

86.3

491

1471

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

86.0

619

2081

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

86.0

1165

5018

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.9

85.8

429

1198

G04CA01

ATC

alfuzosin; oral

1.5

85.5

2846

15578

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.1

85.4

386

1017

G04BD11

ATC

fesoterodine; oral

2.3

85.4

710

2545

C07AB03

ATC

atenolol; systemic

1.8

85.3

1415

6494

N07

ICPC

Convulsion/seizure

13.7

85.3

Z11

ICPC

Compliance/being ill problem

4.7

85.3

215

374

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.6

85.0

174

250

-1, ,

NOMESCO Finland

1.3

84.9

7654

49745

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

3.3

84.8

342

840

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

3.0

84.8

397

1068

ZYY01

NOMESCO Finland

Contact between professionals

6.7

84.8

146

175

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.8

84.8

466

1371

T08

ICPC

Weight loss

3.0

84.7

401

1086

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

12.4

84.5

L60.0

ICD-10 Finland

Ingrowing nail

1.9

84.3

1064

4475

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.2

84.2

244

475

H25.8

ICD-10 Finland

Other senile cataract

1.5

84.1

2608

14056

C01BD01

ATC

amiodarone; systemic

2.3

84.1

707

2546

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.1

84.0

848

3288

Z72.2

ICD-10 Finland

Drug use

6.4

83.8

152

193

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

83.7

838

3238

J20

ICD-10 Finland

Acute bronchitis

1.6

83.7

2246

11712

A91

ICPC

Abnormal result investigation NOS

1.9

83.7

1113

4764

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.3

83.6

655

2288

M01AE02

ATC

naproxen; oral, rectal

1.3

83.6

13855

97325

M54.1

ICD-10 Finland

Radiculopathy

2.1

83.6

844

3273

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

83.3

589

1964

S01

ICPC

Pain/tenderness of skin

2.0

83.3

1041

4363

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.3

83.2

340

842

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

83.2

1586

7576

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.1

82.9

190

304

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

82.7

1443

6721

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1807

5393

2.80

323.31

2.3

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1974

6180

2.68

322.61

5.4

4.7

0.87

0.90

2.69

1896

5772

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1104

2458

3.71

318.15

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

851

1556

4.50

317.86

2.3

1.6

89.65

89.85

0.35

838

1532

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2841

10645

2.27

315.57

2.5

2.3

20.91

23.42

au/ml

0.53

145

882

(3022313) Gas panel - Capillary blood

2142

7067

2.55

315.00

4.8

3.4

—

(3029937) Albumin [Presence] in Urine by Test strip

8601

46693

1.68

312.00

5.8

3.5

0.00

estimate

0.31

3249

15063

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1010

2150

3.88

309.86

5.5

5.3

6137.56

870.76

iu/ml

0.64

153

339

(3035637) Corticotropin [Mass/volume] in Plasma

856

1608

4.38

309.23

1.6

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

4481

20092

1.93

309.14

2.2

2.3

149.24

125.28

ug/g

2.44

3545

15705

(3031040) Bacteria [#/volume] in Urine by Automated count

22123

117527

2.94

307.65

7.2

3.8

1817.75

1431.94

e6/l

0.41

328

1695

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1221

2588

3.91

307.65

1.7

1.4

—

(3018010) Neutrophils/100 leukocytes in Blood

16716

81325

2.47

307.65

7.3

5.1

58.97

56.95

77.80

15784

75602

(3019198) Lymphocytes [#/volume] in Blood

17918

87178

2.62

307.65

7.3

5.1

1.83

1.96

e9/l

14.85

15963

76252

(3033658) Prothrombin time (PT) actual/Normal

9872

42088

2.32

307.65

6.0

3.3

85.22

90.27

65.39

9621

41011

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1570

4024

3.26

307.65

1.5

1.4

265.81

272.69

ug/g

0.56

936

2308

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3854

7821

4.40

307.65

2.1

1.5

—

(3026782) Osmolality of Urine

9426

31842

3.01

307.65

3.9

2.5

520.33

556.78

mosm/kgh2o

46.28

8266

26827

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1730

4306

3.37

307.65

2.9

3.2

41.35

45.04

mg/l

0.48

1382

3515

(3014576) Chloride [Moles/volume] in Serum or Plasma

6042

18942

2.96

307.65

8.1

6.5

103.87

104.68

mmol/l

26.44

6037

18929

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7492

25878

2.77

307.65

4.1

2.6

2.99

2.71

e6/l

1.06

4240

13613

(3002032) Base excess in Venous blood by calculation

5647

13076

4.05

307.65

5.1

3.3

1.97

1.79

mmol/l

2.74

4941

10903

(3024928) Oxygen saturation in Venous blood

1390

2898

4.00

307.65

3.7

3.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9113

21862

4.38

307.65

2.3

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

12167

45381

2.94

307.65

4.5

2.7

0.48

0.42

e6/l

1.77

9777

33391

(3007164) IgA [Mass/volume] in Serum or Plasma

6889

31665

1.97

307.65

1.6

1.4

2.54

2.39

g/l

5.44

4145

18484

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3000

9444

2.73

307.65

9.7

8.8

0.66

0.67

0.44

2971

9391

(3034860) Kappa light chains.free [Mass/volume] in Serum

1735

4316

3.37

307.65

2.9

3.2

91.65

72.78

mg/l

0.22

1390

3522

(3037467) Urinalysis macro (dipstick) panel - Urine

22099

123781

2.64

307.65

6.4

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11705

41109

3.11

307.65

2.7

2.1

2.96

2.91

mg/l

1.21

10037

34662

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

23894

136568

2.98

307.65

10.5

6.1

82.85

77.72

u/l

37.31

22852

127317

(3004588) Protein electrophoresis panel - Serum or Plasma

3408

9572

3.10

307.65

2.3

2.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

18041

74749

3.35

307.65

8.1

5.0

1.21

mmol/l

21.31

16906

66998

(3016502) Oxygen saturation in Arterial blood

4834

15461

2.81

307.65

8.0

7.3

95.32

95.73

3.74

4673

14871

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1493

3673

3.39

307.65

2.3

2.1

0.00

g/l

0.83

1345

3312

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3727

11620

2.80

307.65

4.2

3.5

99.03

86.92

ng/l

7.36

3174

9946

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8115

36446

2.08

307.65

1.9

1.6

24775153.74

33689658.06

pmol/l

0.74

6769

29784

(3009261) Glucose [Presence] in Urine by Test strip

16216

88299

2.04

307.65

5.3

3.2

0.00

estimate

0.07

3327

15288

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2012

6279

2.69

307.65

5.3

4.6

1.65

0.04

1930

5870

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12084

45910

2.87

307.65

3.8

2.7

1888.81

1389.91

ng/l

19.79

10431

38897

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4091

12804

2.82

307.65

3.0

2.1

5.72

7.96

ug/l

8.51

3430

11103

(3000850) Epithelial cells [#/volume] in Urine

9431

33553

2.84

307.65

3.4

2.3

5.84

5.56

e6/l

0.64

8600

29578

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2030

5370

3.19

307.65

2.1

3.72

3.73

g/l

0.10

1799

4780

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2669

6288

3.65

307.65

3.8

2.4

0.66

0.65

0.39

2662

6269

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3347

6518

4.52

307.65

5.2

3.6

24.24

24.02

mmol/l

3.08

3275

6367

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3148

9116

2.99

307.65

4.3

3.3

1.85

1.68

mmol/l

1.44

2372

6622

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1642

4166

3.30

307.65

2.2

2.0

36.09

38.44

g/l

34.78

1406

3560

(3021589) Normoblasts [#/volume] in Blood

14432

78037

1.94

307.65

13.9

7.9

0.00

e9/l

0.86

11915

63356

(3052851) Hemolysis interference index of Serum or Plasma

1694

4600

3.08

307.65

3.7

2.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5495

17228

2.92

307.65

7.6

6.9

5.07

5.10

kpa

1.28

5250

16407

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2500

8422

2.51

307.65

10.0

9.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

4738

10779

4.01

307.65

4.5

2.7

4.53

4.58

kpa

0.84

4582

10418

(3028271) Lactate [Moles/volume] in Capillary blood

1033

1949

4.38

307.65

2.5

1.7

1.73

1.74

mmol/l

0.06

1012

1897

(3023368) Bacteria identified in Blood by Culture

13154

39363

4.00

307.65

5.9

3.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5669

17065

3.06

307.65

2.7

2.3

1.87

1.72

17.55

4971

14863

(3027801) Oxygen [Partial pressure] in Arterial blood

5492

17219

2.92

307.65

7.6

6.9

11.74

12.58

kpa

24.36

5239

16404

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4218

16718

2.20

307.65

5.0

2.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4405

14287

2.73

307.65

8.4

7.7

119.51

121.83

g/l

10.13

4326

13886

(3028626) Oxygen [Partial pressure] in Capillary blood

1454

3443

3.52

307.65

3.7

3.1

8.22

8.31

kpa

0.98

1419

3365

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2989

9479

2.71

307.65

9.6

8.7

1.41

1.34

3.33

2960

9419

(3002030) Lymphocytes/100 leukocytes in Blood

16968

82575

2.50

307.65

7.6

5.3

25.82

28.34

144.08

16023

76825

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2085

3446

5.16

307.65

1.4

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4095

11790

3.08

307.65

2.4

65.32

66.94

g/l

27.57

3692

10582

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3712

7786

4.24

307.65

1.7

1.4

—

(3022096) Basophils/100 leukocytes in Blood

16323

76597

2.56

307.65

7.3

5.3

0.62

0.68

41.87

15375

70638

(3021901) Oxygen saturation in Capillary blood

1139

2543

3.71

307.65

2.8

2.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

9114

30484

3.02

307.65

2.0

1.7

1149.51

1155.17

nmol/l

0.21

7002

22498

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3533

8869

3.50

307.65

7.2

6.9

25.01

24.73

mmol/l

3.63

3491

8791

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8000

29765

2.58

307.65

3.3

2.8

2.46

2.45

mmol/l

14.97

6916

25723

(3020779) Urea [Moles/volume] in Serum or Plasma

4724

13048

3.27

307.65

8.2

6.0

10.30

9.86

mmol/l

3.18

4474

12319

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1524

2832

4.51

307.65

1.3

1.2

539.47

519.12

mg/l

0.26

1455

2688

(3013115) Eosinophils [#/volume] in Blood

18025

87541

2.64

307.65

7.6

5.2

0.18

0.20

e9/l

16.50

15954

75792

(3019060) Gas panel - Arterial blood

3030

9881

2.63

307.65

4.9

4.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7299

22849

3.07

307.65

2.4

1.9

30.10

29.82

2.74

7093

22118

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1349

2453

4.59

307.65

1.3

1.2

3.82

3.77

mmol/l

0.61

1258

2304

(3009343) pH of Capillary blood

3243

9414

2.99

307.65

4.3

3.3

7.42

0.46

541

1062

(3014111) Lactate [Moles/volume] in Serum or Plasma

5063

12522

3.71

307.65

7.2

6.8

1.40

1.34

mmol/l

3.15

4950

12176

(3019069) Monocytes/100 leukocytes in Blood

16745

79875

2.55

307.65

7.7

5.5

8.70

8.52

9.22

15805

74035

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

22285

140122

2.08

307.65

5.1

3.8

14.93

14.77

pmol/l

15.73

20555

126231

(3021601) Nitrite [Presence] in Urine by Test strip

16092

87314

2.04

307.65

7.1

4.3

0.00

estimate

3.27

3421

15674

(3006504) Eosinophils/100 leukocytes in Blood

16656

79389

2.54

307.65

7.4

5.2

2.67

2.91

32.72

15715

73461

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15986

71148

2.72

307.65

2.5

1.9

92.03

96.38

pmol/l

24.86

9081

35943

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11878

67512

1.69

307.65

5.7

3.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

952

1825

4.30

307.65

1.7

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

13032

49624

2.96

307.65

4.6

2.8

58.08

108.55

e6/l

6.03

10529

36811

(40760892) CBC W Ordered Manual Differential panel - Blood

16831

78684

2.64

307.65

7.7

5.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1920

5045

3.20

307.65

2.2

2.1

10.27

10.23

g/l

0.11

1673

4416

(3015736) pH of Urine

13417

70051

1.98

307.65

4.7

3.0

5.96

5.87

1.85

633

5273

(40760888) Immunoglobulin light chains.free panel - Serum

1307

3181

3.41

307.65

2.8

3.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2030

5382

3.18

307.65

2.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9223

33277

2.77

307.65

2.2

1.6

1.31

1.26

mg/l

0.45

7169

25207

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5670

13119

4.05

307.65

5.1

3.3

5.85

5.81

kpa

2.30

5518

12727

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1484

3514

3.52

307.65

3.1

2.9

24.87

24.77

mmol/l

0.32

1443

3434

(1616796) Gas panel - Central venous blood

1538

3007

4.28

307.65

3.5

3.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1905

5027

3.19

307.65

2.2

2.1

3.08

2.87

g/l

13.46

1672

4430

(3007853) Bacteria identified in Skin by Aerobe culture

5032

18758

2.39

307.65

2.1

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1690

4165

3.40

307.65

2.8

3.2

13.37

3.09

ratio

0.84

104

324

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2223

4883

3.88

307.65

2.1

1.8

2.08

2.33

ug/l

0.43

1899

4260

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19768

82488

3.71

307.65

9.0

5.6

1.21

1.22

mmol/l

11.73

17057

69278

(3001122) Ferritin [Mass/volume] in Serum or Plasma

15890

75316

2.48

307.65

3.7

2.6

148.14

116.43

ug/l

25.47

14673

69434

(3015377) Calcium [Moles/volume] in Serum or Plasma

13246

56205

2.60

307.65

3.6

3.0

2.34

2.36

mmol/l

26.88

11630

48766

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19174

85999

3.19

307.65

7.8

5.0

11.35

11.80

umol/l

4.23

18276

80947

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2436

4233

4.95

307.65

2.3

580.23

621.58

ug/l

0.14

2272

3934

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4359

9711

4.05

307.65

1.9

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2416

6355

3.24

307.65

5.9

3.3

48.61

47.40

1.43

2398

6277

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4701

14096

3.00

307.65

3.3

2.1

38.58

50.32

u/l

0.87

4032

11968

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

671

939

5.86

307.65

1.5

1.6

—

(40758558) Short blood count panel - Blood

9612

42080

2.23

307.65

9.0

5.7

—

(3003181) Sodium [Moles/volume] in Urine

1301

2052

5.29

307.65

1.6

1.3

59.69

65.06

mmol/l

3.84

1057

1607

(3027315) Oxygen [Partial pressure] in Blood

1462

3039

4.02

307.65

4.5

3.7

8.69

8.65

kpa

0.36

1423

2962

(40767503) Oxygen content in Capillary blood by calculation

1335

2805

3.96

307.65

3.0

2.3

16.22

16.57

1.85

714

1510

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14848

71067

2.34

307.65

2.6

2.1

75.97

1373.33

nmol/l

0.50

13334

63287

(3019550) Sodium [Moles/volume] in Serum or Plasma

27088

190829

2.43

307.65

33.6

12.7

139.13

139.77

mmol/l

256.73

26672

184938

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15257

60952

3.06

307.65

5.8

2.9

51.85

75.15

ng/l

1.17

11473

40031

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18934

117924

1.79

307.65

4.3

2.7

59.59

45.11

u/l

52.53

17703

109286

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2780

7856

3.04

307.65

9.3

9.1

24.55

24.25

mmol/l

4.05

2644

7587

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1949

5931

2.76

307.65

2.5

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12813

50444

2.82

307.65

3.3

2.2

57.13

64.03

u/l

2.14

11999

46069

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5616

16474

3.14

307.65

4.0

3.6

241.34

243.08

u/l

0.30

5287

15462

(40768797) Stomach Pathology biopsy report

5322

22139

2.14

307.65

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

10525

37999

2.89

307.65

1.8

1.5

19.22

20.74

nmol/l

18.62

9278

31996

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1929

4671

3.48

307.65

3.2

2.8

0.34

0.35

u/ml

0.52

1139

2591

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7580

37790

1.82

307.65

1.4

1.3

1.32

1.77

u/ml

2.88

1876

9952

(3022948) Iron [Moles/volume] in Serum or Plasma

8054

24573

3.24

307.65

2.9

2.2

12.10

13.49

umol/l

43.74

7465

22754

(3000991) Gas panel - Venous blood

4743

12227

3.52

307.65

8.9

7.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8142

23510

3.45

307.65

3.9

2.9

0.81

0.82

mmol/l

22.32

7603

21813

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9160

29773

3.12

307.65

5.6

3.1

222.35

652.39

ng/l

13.34

7430

23058

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2729

6422

3.66

307.65

3.8

2.5

1.29

1.22

2.04

2721

6397

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6587

19366

3.22

307.65

6.6

4.9

1.05

1.04

mmol/l

1.46

6112

17862

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1363

2497

4.55

307.65

1.5

1.4

3045.12

2954.59

e6/l

0.01

1100

2023

(3001604) Monocytes [#/volume] in Blood

17624

84217

2.65

307.65

7.1

5.1

0.61

0.59

e9/l

19.97

15377

71877

(3028026) IgM [Mass/volume] in Serum or Plasma

2636

8125

2.77

307.65

1.9

1.8

1.33

1.35

g/l

0.11

2391

7334

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3540

13024

2.35

307.65

4.7

3.2

1.22

1.23

mmol/l

8.52

3160

11032

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2824

10150

2.37

307.65

3.1

3.4

4.34

4.52

pmol/l

16.63

2474

9035

(3023183) Ammonium ion [Moles/volume] in Plasma

1880

2465

6.48

307.65

3.1

2.3

32.65

34.09

umol/l

1.30

1680

2200

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3279

9524

2.99

307.65

4.3

3.3

5.15

kpa

0.12

3130

8939

(3013512) EKG study

9396

49943

1.75

307.65

5.5

3.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

17920

76814

3.17

307.65

20.0

13.8

1.29

1.28

inr

0.37

5365

21145

(3013290) Carbon dioxide [Partial pressure] in Blood

1461

3021

4.04

307.65

4.5

3.7

5.02

4.99

kpa

0.52

1422

2945

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2035

5388

3.19

307.65

2.1

7.49

7.34

g/l

2.84

1803

4788

(3018418) pH of Serum or Plasma

12841

47572

3.04

307.65

5.2

3.4

7.40

1.31

2496

8558

(3006315) Basophils [#/volume] in Blood

17676

84433

2.66

307.65

7.2

5.1

0.04

e9/l

7.99

15414

71992

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5651

12159

4.37

307.65

2.3

2.2

377.01

381.34

nmol/l

0.67

5196

11113

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6729

14578

4.50

307.65

2.2

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

5226

21028

2.21

307.65

1.5

1.3

475.55

566.58

titre

3.05

1049

4307

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13977

45990

3.70

307.65

2.8

1.9

220.89

210.40

u/l

0.34

13308

42537

(3044889) 12 lead EKG panel

19660

126316

1.73

307.65

4.9

3.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2073

5936

2.94

307.65

1.5

13.42

16.70

u/ml

0.42

159

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1600

2657

5.06

307.65

1.5

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1472

3615

3.39

307.65

2.3

2.1

0.00

g/l

-0.00

1340

3301

(3009466) Valproate [Moles/volume] in Serum or Plasma

1151

1530

6.25

307.65

6.0

4.8

369.49

367.75

umol/l

0.12

1017

1278

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1278

2661

3.99

307.65

1.6

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3003

9458

2.73

307.65

9.8

8.8

93.47

94.08

4.96

2984

9424

(3010421) pH of Blood

1628

3542

3.85

307.65

4.5

3.5

7.42

0.17

1471

3233

(3013707) Erythrocyte sedimentation rate by Westergren method

22197

132318

2.33

307.65

5.2

3.6

15.41

11.55

mm/h

190.20

20702

121211

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4028

13232

2.67

307.65

3.6

2.6

274.84

200.76

ng/l

11.29

3654

12082

(3012501) Base excess in Blood by calculation

1461

3019

4.04

307.65

4.5

3.7

2.50

2.54

mmol/l

0.17

1026

1992

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5246

17832

2.66

307.65

3.3

2.4

8.57

8.77

umol/l

0.26

4492

15424

(3024561) Albumin [Mass/volume] in Serum or Plasma

17000

71467

3.10

307.65

5.8

4.1

34.13

35.81

g/l

227.43

15833

65723

(3005719) IgG [Mass/volume] in Serum or Plasma

3383

10349

2.84

307.65

2.6

2.5

10.53

10.77

g/l

1.89

3082

9375

(3011397) Hemoglobin [Presence] in Urine by Test strip

8305

40660

1.89

307.65

4.7

3.2

—

(3044290) Cell count panel - Cerebral spinal fluid

1261

2341

4.48

307.65

1.4

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

10925

54727

1.95

307.65

3.2

2.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1754

4560

3.22

307.65

2.3

0.83

0.98

g/l

0.76

1489

3855

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7940

27728

2.77

307.65

3.8

2.4

1.25

1.12

e6/l

1.29

4660

15381

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6657

14753

4.38

307.65

2.2

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14464

83805

1.75

307.65

3.2

2.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

26939

185431

2.62

307.65

29.7

10.6

23.62

24.18

mg/l

2.25

24194

141296

(3042936) Bacteria identified in Isolate by Culture

5810

21859

2.41

307.65

2.4

1.8

—

(3018095) Leukocytes [#/volume] in Urine

14115

59564

2.71

307.65

5.4

3.2

101.98

107.57

e6/l

0.28

10994

40025

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1577

3953

3.33

307.65

2.3

2.1

0.05

0.02

g/l

0.79

1423

3581

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2801

9477

2.52

307.65

7.5

6.7

24.77

24.51

mmol/l

2.82

2702

9007

(3013826) Glucose [Moles/volume] in Serum or Plasma

21085

99459

3.36

307.65

7.2

3.9

6.81

6.73

mmol/l

4.25

20335

91514

(3012544) pH of Venous blood

5758

13658

3.96

307.65

5.1

3.3

7.39

0.04

(3003396) Base excess in Arterial blood by calculation

5508

17243

2.92

307.65

7.6

6.9

1.30

0.96

mmol/l

6.47

4483

13670

(3035350) Ketones [Presence] in Urine by Test strip

16183

87186

2.07

307.65

5.2

3.2

0.00

estimate

3.37

3610

16671

(3023103) Potassium [Moles/volume] in Serum or Plasma

27091

191385

2.40

307.65

33.8

12.8

3.98

3.97

mmol/l

7.96

26644

185076

(3023520) Reticulocytes [#/volume] in Blood

4230

12452

3.02

307.65

2.8

2.3

70.87

68.73

e9/l

2.68

3118

9319

(3004119) Hemoglobin [Mass/volume] in Venous blood

3281

8704

3.28

307.65

4.6

2.9

126.50

130.03

g/l

13.95

3212

8509

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11560

54752

2.13

307.65

3.9

2.9

34.04

33.38

u/l

0.34

10894

51749

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8491

41141

1.92

307.65

3.1

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7165

20833

3.32

307.65

3.0

2.3

21.77

23.05

9.55

6180

17543

(3026008) Bacteria identified in Urine by Culture

13704

50676

3.16

307.65

4.4

2.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

8441

44690

1.72

307.65

3.0

2.4

3941.81

5238.90

umol/l

2.18

7179

38851

(3027273) Bicarbonate [Moles/volume] in Venous blood

2485

6988

3.03

307.65

4.8

2.9

25.26

25.17

mmol/l

0.64

2421

6772

(36304419) Bacteria [Presence] in Urine

11637

44354

2.81

307.65

4.5

2.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

19545

98766

2.69

307.65

11.7

7.4

4.40

4.11

e9/l

44.47

17303

84740

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1362

2495

4.55

307.65

1.4

18.02

24.87

e6/l

0.49

1045

1921

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2617

6470

3.47

307.65

1.8

1.6

1.58

1.51

g/l

3.12

2264

5455

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7552

22446

3.28

307.65

2.9

2.2

2.25

2.36

g/l

50.42

6965

20562

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4447

14175

2.79

307.65

2.4

2.1

0.20

0.22

g/l

29.80

4034

13204

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1600

2658

5.06

307.65

1.5

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

25024

170693

2.07

307.65

6.3

4.4

2.01

2.16

mu/l

0.64

23335

155085

(3017181) Myelocytes/100 leukocytes in Blood

3244

12959

2.14

307.39

4.3

3.6

0.91

0.01

1308

3739

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1046

2320

3.72

302.94

1.2

1.3

287.95

263.71

u/ml

1.52

703

1447

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2618

9638

2.30

302.52

1.3

43.36

54.24

au/ml

1.20

528

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1599

4680

2.85

296.16

1.6

1.5

142.84

245.57

titre

2.04

200

(3020891) Body temperature

1827

5747

2.66

295.19

5.9

4.4

—

(3025941) Bacteria identified in Stool by Culture

2445

8867

2.33

292.09

1.4

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1817

5746

2.64

290.40

1.8

38.28

38.93

u/l

0.63

1571

5047

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3913

17179

1.96

285.35

3.5

4.0

33.79

22.90

ug/l

1.02

3191

13872

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1380

3798

3.02

284.89

1.4

16.08

14.99

iu/ml

0.07

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1416

3960

2.97

284.29

1.7

1.5

0.24

0.23

g/l

0.70

1333

3745

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

17495

114122

1.56

283.52

3.5

2.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1070

2524

3.50

283.04

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

1657

5072

2.72

281.96

4.5

4.0

1.44

1.41

mmol/l

0.49

1616

4986

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1447

4121

2.92

281.28

1.7

1.5

1.19

1.16

g/l

1.94

1367

3910

(3008295) Osmolality of Serum or Plasma

708

1231

4.72

280.65

1.5

1.4

278.61

280.58

mosm/kgh2o

0.99

518

962

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

801

1546

4.26

279.52

2.9

2.6

992.18

732.17

u/ml

0.25

(3002179) Metamyelocytes/100 leukocytes in Blood

2945

11761

2.12

277.79

4.1

3.5

0.72

0.65

0.75

1113

3198

(3048929) Epstein Barr virus Ab [Presence] in Serum

1468

4246

2.87

277.48

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1059

2515

3.48

277.24

1.4

15.37

19.55

u/ml

0.58

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4268

19500

1.89

275.52

2.0

1.6

1.63

1.40

49.76

3622

17205

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1879

6209

2.53

274.38

5.1

3.5

24.80

24.77

mmol/l

0.19

1748

5709

(3019230) Fractional oxyhemoglobin in Venous blood

1024

2395

3.53

274.27

4.0

2.6

60.43

65.47

8.54

1019

2388

(3017143) Hepatitis C virus Ab [Presence] in Serum

4034

18146

1.91

272.85

1.7

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

772

1476

4.29

272.61

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1197

3112

3.18

271.75

1.6

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

3045

12456

2.08

269.28

4.3

3.7

0.09

0.10

0.11

1121

3251

(3037756) Immunofixation for Serum or Plasma

1122

2837

3.27

266.38

1.5

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

8458

47222

1.61

266.01

5.0

2.9

—

(3023410) Appearance of Cerebral spinal fluid

664

1149

4.73

264.62

1.6

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

679

1234

4.51

255.23

1.5

1.4

—

(3036489) Thrombin time

1711

5610

2.54

253.42

2.4

1.8

22.22

21.59

1.82

1523

4867

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

971

2321

3.45

251.50

1.4

111.68

111.61

u/ml

0.01

241

514

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

24386

174013

1.67

248.96

26.2

10.6

77.65

81.23

ml/min/173m2

97.18

21473

139846

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

897

2047

3.60

248.94

1.5

1.3

—

(3016038) Potassium [Moles/volume] in Urine

518

759

5.57

247.72

1.4

1.3

32.44

36.11

mmol/l

2.32

436

656

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1719

5758

2.49

243.27

1.3

1.2

0.67

0.99

u/ml

0.71

141

504

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1305

3814

2.83

241.51

1.3

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1244

3558

2.89

239.41

2.4

2.1

127.69

130.90

g/l

4.01

990

2506

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

851

1924

3.63

239.34

1.3

1.58

nmol/l

0.00

809

1847

(3025159) Blasts/100 leukocytes in Blood

2846

11864

2.03

237.62

4.3

3.7

0.17

0.26

0.39

923

2730

(46235355) HIV 1 and 2 tests - Meaningful Use set

5786

30097

1.68

236.16

1.9

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

23773

169199

1.62

235.95

7.0

5.5

41.07

39.53

mmol/mol

83.50

21989

155675

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

649

1223

4.34

233.23

1.1

22.07

82.77

au/ml

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

842

1931

3.58

231.89

1.3

0.27

0.26

nmol/l

0.06

129

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1410

4392

2.66

231.09

2.8

2.2

3.57

3.61

g/l

0.31

1347

4176

(3019150) Specific gravity of Urine by Refractometry

6978

38255

1.61

230.56

5.6

3.6

1.02

kg/l

0.13

1038

6022

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

815

1839

3.64

229.82

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

815

1840

3.64

229.64

1.6

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1500

4857

2.56

227.44

2.7

2.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

26919

198611

1.86

227.43

32.1

13.0

83.51

76.57

umol/l

110.15

26903

198531

(3043409) Potassium [Moles/volume] in Arterial blood

1399

4396

2.64

225.28

4.9

4.2

3.88

3.90

mmol/l

1.17

1380

4363

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

636

1215

4.28

224.64

1.7

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

788

1770

3.65

223.64

1.5

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1355

4208

2.67

223.27

1.8

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

408

538

6.17

216.58

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

22852

162151

1.56

216.45

33.5

13.3

15.00

15.10

0.72

22584

158756

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

771

1756

3.60

214.40

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

397

517

6.25

213.25

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

728

1608

3.71

211.59

6.5

5.7

12.14

11.57

mg/l

2.25

665

1475

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

491

793

5.05

211.56

1.3

1.2

2.01

2.10

mmol/l

0.77

455

739

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1170

3489

2.77

208.17

1.9

12.63

10.73

mg/l

3.87

1065

3246

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

695

1509

3.77

206.94

1.5

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1070

3053

2.89

206.45

1.5

1.2

—

(3047181) Lactate [Moles/volume] in Blood

1454

4862

2.48

205.81

5.9

5.4

1.31

1.28

mmol/l

0.68

1321

4288

(40761535) Cells panel - Urine sediment

3048

13639

1.89

205.59

4.4

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1056

2999

2.90

205.46

3.5

2.9

0.83

0.79

nmol/l

1.37

834

2301

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

583

1116

4.27

205.35

1.5

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

9409

56363

1.50

203.97

3.5

3.1

6.97

7.66

mmol/l

37.53

7803

47292

(40761511) CBC panel - Blood by Automated count

26465

195602

1.74

200.06

25.7

10.7

—

(3008037) Lactate [Moles/volume] in Venous blood

1142

3433

2.74

200.04

5.4

2.6

1.62

1.61

mmol/l

0.13

1121

3368

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

710

1603

3.63

199.91

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

581

1140

4.16

198.26

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

3915

19152

1.74

196.38

1.6

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

458

746

5.00

195.47

1.1

1.42

8.86

nmol/l

2.51

152

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2115

8513

2.07

192.51

3.4

2.5

0.35

0.28

e6/l

1.03

2074

8277

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1377

4639

2.45

191.60

2.6

2.1

91.20

91.41

0.11

1327

4422

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

361

488

6.01

187.10

2.3

1.7

119.62

163.38

umol/l

1.21

203

248

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26819

199676

1.74

185.92

15.5

8.7

25.14

25.92

u/l

5.86

26088

191396

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2158

8874

2.03

185.14

2.5

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1285

4273

2.48

183.71

2.8

2.2

205.13

185.76

9.47

1219

4036

(3028707) Methadone [Presence] in Urine by Screen method

835

2230

3.07

180.62

4.0

2.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5290

28584

1.59

179.30

1.4

1.2

39.25

39.44

iu/ml

0.01

1547

9187

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

473

856

4.50

178.58

1.7

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

525

1036

4.13

177.81

1.6

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1325

4553

2.40

176.38

1.3

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

504

974

4.22

175.35

1.8

1.2

1.18

1.38

promille

1.86

394

757

(3020682) Albumin/Creatinine [Ratio] in Urine

9140

55709

1.46

175.23

4.0

3.8

14.80

7.52

mg/mmol

20.30

5926

34618

(42529406) Shigella sp [Presence] in Stool by Culture

1323

4562

2.39

174.74

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1314

4518

2.40

174.65

1.3

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

438

768

4.64

171.75

17.0

17.2

3093.16

1426.91

nmol/l

0.51

423

734

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

373

569

5.33

170.99

1.6

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1008

3089

2.68

169.89

1.5

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

1051

3293

2.62

169.58

5.7

2.6

7.64

7.70

mmol/l

0.24

1033

3238

(3000330) Specific gravity of Urine by Test strip

2070

8667

1.99

168.35

5.3

2.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1524

5679

2.22

168.12

3.0

3.3

1289.53

1261.42

u/ml

0.02

1285

4866

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

419

725

4.70

166.88

12.5

12.2

806.24

835.14

nmol/l

0.47

407

700

(3003327) Ova and parasites identified in Stool by Light microscopy

1439

5262

2.26

166.05

1.7

—

(40761536) Microorganisms panel - Urine sediment

3073

14733

1.76

163.34

5.9

3.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

715

1859

3.15

161.67

3.6

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

887

2622

2.77

160.04

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

489

997

4.00

158.63

1.2

1.1

36.97

44.31

mg/l

2.77

399

835

(44816559) Phosphatidylethanol [Mass/volume] in Blood

899

2702

2.73

157.18

1.5

1.3

—

(3036180) Methadone [Presence] in Urine

340

516

5.35

156.72

3.3

1.7

—

(36660697) Celiac disease serology panel - Serum

2876

13703

1.76

155.78

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

24497

180090

1.51

155.34

5.3

4.4

6.11

5.91

mmol/l

71.26

22248

163658

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

560

1279

3.57

154.94

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

560

1280

3.57

154.76

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1171

4043

2.38

153.96

4.2

3.1

1.76

1.46

mg/l

21.66

1053

3674

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2513

11551

1.82

153.44

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

470

957

4.00

152.73

1.1

260.54

271.69

mg/l

0.41

411

850

(3019225) pH of Specimen

3356

16780

1.69

152.66

5.8

3.5

—

(3012516) Albumin [Mass/volume] in Urine

8601

52928

1.43

151.61

3.4

3.2

530.06

350.29

mg/l

2.58

5769

33084

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

887

2698

2.70

151.53

1.2

187.14

137.31

titre

0.34

(3007566) Smooth muscle Ab [Titer] in Serum

1176

4110

2.36

150.43

1.2

111.78

141.56

titre

0.60

101

365

(3034770) Mitochondria Ab [Titer] in Serum

1165

4065

2.36

149.55

1.2

579.64

1082.71

titre

2.39

129

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1247

4519

2.27

146.70

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

447

906

4.01

146.15

1.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

447

906

4.01

146.15

1.6

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

447

906

4.01

146.15

1.6

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

401

749

4.35

145.64

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

452

927

3.97

145.48

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

762

2188

2.85

144.99

1.5

0.74

0.78

g/l

0.31

578

1664

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4875

27028

1.54

143.97

1.3

1.2

11.73

12.82

u/ml

0.45

1684

10438

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

394

738

4.34

142.60

1.5

1.4

5.20

5.88

u/l

1.55

327

621

(3000012) Reticulocyte production index

725

2047

2.90

142.19

2.4

2.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

411

803

4.16

141.01

1.5

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2482

11676

1.77

139.70

1.3

1.2

110.95

152.08

iu/ml

5.83

815

4399

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

403

792

4.14

137.22

1.5

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

252

332

6.15

133.94

2.8

2.4

56.63

50.58

umol/l

1.47

202

281

(3042111) Morphology [Interpretation] in Bone marrow Narrative

723

2118

2.79

132.55

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

1071

17864

0.46

132.33

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

320

539

4.82

131.53

2.3

2.6

981.60

919.25

u/ml

0.18

313

534

(3049717) Cytology report of Urine Cyto stain

1569

6515

1.99

129.72

2.5

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4574

25523

1.52

129.68

1.7

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

731

2184

2.74

129.14

3.3

3.0

1.52

1.42

0.31

643

1893

(3011985) Renin [Units/volume] in Plasma

694

2017

2.81

129.10

1.8

1.5

61.16

65.96

mu/l

0.24

603

1814

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

313

526

4.83

129.00

1.2

66.42

65.72

0.03

(3024666) Lithium [Moles/volume] in Serum or Plasma

381

756

4.09

128.13

13.7

11.5

0.64

0.62

mmol/l

1.05

351

690

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1120

4119

2.23

126.99

1.3

1.2

29.88

37.57

u/ml

0.45

241

(3003434) Protein [Mass/volume] in Pleural fluid

698

2064

2.76

125.72

1.5

1.4

30.33

33.69

g/l

8.68

615

1851

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

362

705

4.17

124.74

1.6

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

711

2149

2.70

122.83

1.4

—

(3045414) Leukocytes [Presence] in Urine

1701

7443

1.89

120.35

2.3

1.7

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

411

905

3.69

119.91

2.6

3.6

110.57

142.70

nmol/l

0.95

398

892

(4035726) Immunohistochemistry procedure

2824

14323

1.65

119.85

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

748

2355

2.60

119.26

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1386

5693

2.01

117.92

1.7

1.6

350.59

306.60

mu/l

2.20

1253

5159

(3022145) Colonoscopy Study observation

3569

19240

1.56

117.34

1.3

—

(3037121) Protein [Mass/volume] in Urine

1344

5474

2.02

117.05

3.1

0.35

0.30

g/l

1.28

652

2256

(3023199) Leukocytes [#/volume] in Pleural fluid

628

1835

2.79

115.65

1.5

1.4

2918.33

2397.21

e6/l

0.27

449

1329

(3022621) pH of Urine by Test strip

2353

11476

1.70

115.64

4.0

2.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

827

2778

2.43

115.19

3.3

2.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1018

3750

2.23

114.85

1.3

6.09

5.78

u/ml

0.03

395

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1028

3809

2.21

114.35

1.3

7.38

8.16

u/ml

0.12

138

613

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1233

4917

2.06

113.68

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

323

628

4.17

111.57

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

323

628

4.17

111.57

1.4

—

(3011412) CD3 cells [#/volume] in Blood

443

1077

3.34

111.53

2.1

2.2

1.21

1.20

e9/l

0.07

389

961

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

451

1113

3.29

110.91

1.7

2.4

18.86

18.60

nmol/l

0.21

413

1072

(3039000) Anion gap in Blood

959

3498

2.25

110.76

6.8

6.2

11.25

11.15

mmol/l

0.44

895

3135

(3018572) Chloride [Moles/volume] in Blood

959

3499

2.25

110.68

6.8

6.2

104.69

105.35

mmol/l

3.31

895

3136

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

582

1676

2.83

110.09

2.8

3.4

6.08

9.22

nmol/l

0.45

559

1630

(3005322) IgE [Units/volume] in Serum or Plasma

2094

10035

1.73

109.43

1.4

1.3

246.72

244.40

u/ml

0.03

1933

9265

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1133

4440

2.09

109.35

1.5

3.50

6.55

iu/ml

0.37

273

948

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

871

3066

2.32

109.30

1.2

1.88

15.45

u/ml

1.72

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

618

1845

2.73

109.29

1.6

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

521

1419

2.99

108.84

3.5

3.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

606

1795

2.75

108.78

7.6

9.5

7.52

7.41

mmol/l

0.17

528

1427

(3028308) Erythrocytes [#/volume] in Pleural fluid

578

1674

2.81

108.19

1.5

1.4

76452.53

50391.30

e6/l

0.78

358

993

(3012441) Differential panel - Pleural fluid

556

1578

2.87

107.99

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

489

1290

3.08

107.88

3.1

2.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

602

1790

2.74

107.28

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

601

1789

2.74

106.88

1.5

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

312

612

4.13

106.56

1.6

1.3

—

(3014271) Vancomycin [Susceptibility]

343

723

3.85

106.42

3.4

2.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

858

3037

2.31

106.29

1.3

1.2

38.00

46.84

u/ml

0.81

103

278

(3025468) Yersinia sp identified in Specimen by Organism specific culture

598

1782

2.73

106.13

1.6

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

601

1796

2.73

106.09

1.5

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

207

285

5.88

105.49

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

312

617

4.10

105.44

1.6

1.3

—

(4062490) Immunoglobulin typing, IgG

501

1359

3.00

105.40

1.4

1.3

—

(3045788) Cell count panel - Pleural fluid

512

1408

2.96

105.18

1.6

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

326

668

3.96

105.12

1.1

1.10

1.04

u/l

0.62

146

291

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

236

378

5.06

102.73

3.1

2.9

28.72

28.40

umol/l

0.13

168

297

(3028192) IgG subclass 2 [Mass/volume] in Serum

497

1364

2.96

102.47

1.4

1.3

2.72

3.05

g/l

3.36

349

958

(3024139) IgG subclass 3 [Mass/volume] in Serum

497

1364

2.96

102.47

1.4

1.3

0.36

0.43

g/l

3.86

350

958

(3027135) IgG subclass 1 [Mass/volume] in Serum

497

1364

2.96

102.47

1.4

1.3

6.62

6.85

g/l

0.53

348

956

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

612

1880

2.65

102.43

1.3

1.4

351.26

327.35

pmol/l

0.20

524

1629

(3024522) Salmonella sp identified in Specimen by Organism specific culture

595

1804

2.69

102.15

1.6

1.3

—

(40768804) Tissue Pathology biopsy report

11011

73834

1.32

102.10

2.3

2.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

856

3093

2.26

101.04

1.3

1.2

5.13

6.34

u/ml

0.17

251

(21494890) Protein electrophoresis panel - 24 hour Urine

516

1462

2.87

100.54

1.7

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

689

2269

2.48

100.08

1.1

—

(40768806) Pleura Pathology biopsy report

544

1600

2.77

98.96

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1534

6904

1.83

98.91

1.1

2.42

9.14

u/ml

0.80

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

551

1635

2.74

98.58

1.3

1.2

32.00

34.38

nmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

189

256

5.97

97.90

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

248

435

4.62

97.32

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

345

783

3.57

96.41

2.0

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

683

2283

2.44

96.10

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

349

807

3.51

94.88

1.6

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

357

843

3.44

94.04

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1688

7934

1.75

94.02

1.1

119.00

257.68

titre

2.07

234

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

186

260

5.79

93.42

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

490

1406

2.83

93.32

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

181

250

5.85

92.00

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

275

551

4.04

91.41

1.2

1.1

3.44

3.75

iu/ml

0.19

(3011288) Drugs identified in Urine by Screen method

988

3935

2.05

91.19

4.0

2.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

251

470

4.32

91.00

1.1

226.11

739.96

ng/l

0.84

122

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

284

585

3.93

90.98

1.5

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

284

585

3.93

90.98

1.5

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1085

4475

1.99

90.94

1.4

1.3

11.11

9.87

u/l

1.85

872

3635

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

290

609

3.86

90.50

2.7

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

27412

210652

1.53

90.23

41.6

16.6

38.59

40.40

142.50

25849

196095

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

175

239

5.92

89.95

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

529

1613

2.67

89.84

1.2

56.02

65.21

u/l

1.95

474

1435

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

180

256

5.69

88.87

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1096

4574

1.96

88.80

3.5

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1004

4062

2.02

88.77

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

609

2009

2.47

88.13

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1085

4526

1.96

88.02

7.1

3.3

—

(3014051) Protein [Presence] in Urine by Test strip

1065

4424

1.97

87.43

3.1

2.3

—

(3007461) Platelets [#/volume] in Blood

27408

210849

1.52

86.57

41.3

16.5

247.97

251.15

e9/l

11.18

26877

204083

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

394

1043

3.07

86.47

1.4

13.36

12.03

umol/l

2.42

367

989

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

415

1133

2.97

86.39

1.2

140.42

175.77

titre

0.47

208

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2511

13367

1.56

85.66

3.6

2.4

60.01

66.85

ml/min/173m2

12.47

1093

5017

(1175426) CD3 cells/100 lymphocytes in Blood

350

867

3.27

85.63

2.0

1.9

74.39

71.05

3.33

332

838

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

413

1132

2.96

85.39

1.2

70.00

127.40

titre

—

(3035941) MCH [Entitic mass]

27414

210991

1.51

85.24

41.1

16.4

30.29

30.27

0.57

27083

207291

(3036782) Glucose [Moles/volume] in Pleural fluid

478

1425

2.73

84.79

1.3

1.4

6.52

6.25

mmol/l

1.05

442

1315

(3024731) MCV [Entitic volume]

27414

211021

1.51

84.78

41.2

16.4

91.41

90.87

62.39

27088

207308

(3010813) Leukocytes [#/volume] in Blood

27416

211055

1.51

84.54

41.3

16.5

7.12

6.70

e9/l

44.31

26821

203529

(3026361) Erythrocytes [#/volume] in Blood

27414

211041

1.51

84.47

41.3

16.5

4.32

4.51

e12/l

307.65

26817

203529

(3051611) Lipemic interference index of Serum or Plasma

532

1685

2.57

83.79

3.8

3.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

27415

211102

1.51

83.68

41.6

16.6

129.53

135.96

g/l

307.65

27088

207406

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

341

850

3.25

82.62

2.0

1.9

13.92

15.59

1.61

330

833

(3017354) Segmented neutrophils/100 leukocytes in Blood

454

1337

2.76

82.43

3.3

3.0

59.23

55.36

2.89

375

1091

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

287

643

3.62

81.79

1.6

6.74

14.98

nmol/l

0.45

227

548

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1331

6084

1.80

81.28

1.7

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

853

3359

2.07

81.10

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8934

59635

1.29

80.28

4.9

5.0

5.16

3.20

ug/l

1.82

7852

53240

(3044927) Protein electrophoresis panel - Urine

467

1422

2.67

79.55

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

241

487

4.01

79.27

30.5

26.7

112.36

120.25

ug/l

0.79

197

412

(3045142) Bone marrow Pathology biopsy report

436

1286

2.75

78.94

1.3

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

322

803

3.25

77.98

2.5

1.9

94.94

98.53

0.94

306

739

(21494815) CD4 cells/100 lymphocytes in Specimen

371

1015

2.97

76.99

2.0

40.25

39.28

0.49

359

999

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

142

185

6.20

76.42

1.9

16.45

16.01

umol/l

0.14

142

185

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

195

344

4.58

76.10

1.2

15.92

18.18

0.13

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

975

4125

1.93

75.82

1.8

1.9

13.46

11.76

iu/l

0.06

324

1525

(3039162) Centromere protein B Ab [Units/volume] in Serum

550

1859

2.41

75.55

1.3

1.2

42.63

57.38

u/ml

0.67

135

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

316

796

3.22

75.32

2.0

2.4

516.54

512.16

e6/l

0.04

256

668

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1034

4474

1.89

75.16

1.5

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

219

429

4.13

75.06

2.4

2.3

137.21

156.42

nmol/l

1.73

187

373

(3023419) Bacteria identified in Sputum by Culture

615

2191

2.28

75.01

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1222

16572

0.58

74.97

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

341

903

3.06

74.85

1.2

100.61

80.38

u/l

3.11

297

784

(3008757) Leukocyte morphology finding [Identifier] in Blood

477

1518

2.55

74.43

3.6

3.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

336

885

3.08

74.42

1.2

28.60

20.24

u/l

2.78

287

748

(3051651) Icteric interference index of Serum or Plasma

326

844

3.13

74.31

3.9

3.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

428

1293

2.69

74.06

1.9

2.4

1.19

0.58

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

256

568

3.65

74.03

1.8

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

168

267

5.09

73.87

1.1

0.65

0.88

umol/24h

0.45

130

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

255

566

3.65

73.70

1.8

1.4

—

(3042631) Mycobacterium sp identified in Specimen

566

1965

2.34

73.26

2.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

305

770

3.21

72.46

2.0

2.4

0.19

0.25

e9/l

5.31

260

665

(3004716) Salmonella sp identified in Stool by Organism specific culture

1686

8485

1.63

72.39

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

377

1080

2.83

72.09

1.2

1.1

—

(3019977) pH of Arterial blood

309

789

3.17

72.07

2.9

2.6

7.41

7.42

0.69

288

(40759836) Histone Ab [Presence] in Serum by Immunoblot

376

1077

2.83

71.92

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

238

514

3.75

71.54

3.2

2.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

376

1081

2.82

71.43

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

377

1089

2.81

71.01

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

376

1086

2.81

70.83

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

376

1088

2.80

70.59

1.2

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

585

2098

2.27

70.26

2.7

2.5

670.07

948.27

u/ml

0.20

576

2072

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

305

787

3.14

69.94

1.2

—

(3017732) Neutrophils [#/volume] in Blood

2190

11835

1.53

69.17

3.4

2.7

5.14

5.01

e9/l

0.19

1676

9491

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

442

1410

2.55

68.66

1.3

479.38

533.16

u/l

0.20

412

1339

(3010838) Calcium [Moles/time] in 24 hour Urine

696

2710

2.09

68.16

1.8

4.75

5.23

mmol/24h

3.15

605

2369

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

410

1267

2.63

67.90

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2143

11576

1.53

67.77

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

600

2212

2.21

67.46

1.3

1.2

3.64

3.75

u/ml

0.11

287

982

(3023511) Choriogonadotropin [Units/volume] in Urine

745

2990

2.03

67.27

1.6

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

149

232

5.19

67.03

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

341

964

2.87

66.83

1.0

734.46

724.85

ng/l

0.13

230

661

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

340

969

2.84

65.67

1.0

39.58

45.23

ng/l

1.07

234

672

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

337

960

2.85

65.15

1.0

304.38

383.91

ng/l

1.17

240

674

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

363

1077

2.73

65.07

1.4

13.86

12.51

u/l

2.37

348

1045

(40757494) Bilirubin.total [Moles/volume] in Blood

276

703

3.18

64.68

2.2

2.3

29.22

44.37

umol/l

0.71

(3045716) Anion gap in Serum or Plasma

247

588

3.40

64.41

2.6

2.3

9.67

10.14

mmol/l

1.03

240

573

(3020911) Cortisol [Moles/time] in 24 hour Urine

218

479

3.68

64.00

1.4

172.55

239.75

nmol/24h

0.30

218

479

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

606

2294

2.15

63.82

1.3

1.2

3.42

3.22

u/ml

0.12

224

782

(4200892) Spirometry reversibility

2273

12584

1.49

63.77

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

138

211

5.28

63.33

1.0

—

(3016879) Cocaine [Presence] in Urine

1188

5646

1.72

63.21

3.6

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

644

2514

2.08

62.65

1.4

1.3

38.68

30.06

u/l

1.01

560

2150

(3010503) CD19 cells [#/volume] in Blood

261

656

3.22

62.52

2.3

2.4

0.16

0.44

e9/l

1.51

250

635

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

338

987

2.78

62.45

1.6

1.9

4.39

3.78

mg/l

1.41

315

934

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

205

439

3.78

62.41

1.8

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

300

831

2.92

61.01

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

156

278

4.53

60.24

1.9

2.0

32.70

25.76

u/l

0.34

142

249

(3000764) Benzodiazepines [Presence] in Urine

1247

6098

1.67

59.67

3.5

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

199

432

3.72

59.46

1.9

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

199

433

3.72

59.27

1.9

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

238

584

3.30

59.26

5.6

3.2

1076.34

2079.81

mg/l

0.36

166

411

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

254

4.67

58.89

1.1

—

(3004451) EKG impression Narrative

257

665

3.13

58.74

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1249

6141

1.66

58.53

2.5

2.1

7339.60

5798.65

u/l

0.69

397

2504

(3017704) Immunofixation for Urine

279

763

2.96

58.06

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

299

851

2.85

57.95

2.2

2.4

707.25

717.85

e6/l

0.09

283

823

(3028300) Cannabinoids [Presence] in Urine

1249

6167

1.66

57.58

3.6

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2217

12460

1.47

57.44

2.4

2.1

11.10

12.18

nmol/l

7.23

1939

11136

(3027008) Opiates [Presence] in Urine

1245

6156

1.65

57.07

3.3

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

177

365

3.92

56.80

1.3

1.1

111.75

112.08

0.05

159

320

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

523

1959

2.17

56.59

1.9

24.69

24.64

ug/l

0.01

510

1916

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

187

403

3.75

56.48

1.3

1.1

0.32

0.30

g/l

1.55

144

319

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

359

1139

2.55

56.47

1.6

1.5

28.64

24.88

u/ml

0.60

239

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

926

4244

1.78

55.87

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

743

3181

1.90

55.73

3.1

651.64

1010.28

u/ml

0.53

667

2880

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

765

3307

1.88

55.72

2.2

1.7

0.86

0.80

nmol/l

1.44

611

2765

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

409

1392

2.38

55.43

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

208

489

3.44

55.36

39.5

33.7

7.08

7.15

ug/l

0.20

192

444

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

789

11112

0.56

55.00

1.4

—

(3033799) Differential panel - Peritoneal fluid

188

416

3.65

54.71

2.4

1.8

—

(3042733) HLA Ab [Presence] in Serum

177

377

3.79

54.36

4.4

5.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

209

499

3.39

54.34

2.5

1.7

580.62

5262.90

e6/l

1.38

144

330

(3006922) Hepatitis E virus Ab [Presence] in Serum

322

987

2.64

54.29

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

426

1491

2.32

54.22

2.4

2.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

170

353

3.89

54.07

1.4

1.2

110.52

130.52

nmol/l

0.73

111

256

(3000492) Spirometry study

2852

16964

1.39

53.81

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

845

3812

1.81

53.74

1.7

1.6

14889.68

13827.87

e6/l

0.27

606

2737

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

307

925

2.69

53.52

1.6

1.5

6.45

6.55

u/l

0.04

245

752

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

227

578

3.18

53.32

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

226

576

3.17

53.01

2.2

1.8

1.88

1.94

umol/l

0.47

207

536

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

350

1132

2.51

52.95

1.1

293.98

289.20

mg/l

0.41

321

996

(3021788) Differential panel - Synovial fluid

677

2861

1.92

52.80

1.6

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

172

368

3.78

52.51

1.9

1.6

9838.52

22334.77

u/ml

0.37

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

436

3.52

52.46

3.2

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

436

3.52

52.46

3.2

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

146

277

4.26

52.27

1.6

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

299

902

2.68

52.02

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

354

1166

2.46

51.55

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

224

578

3.13

51.50

2.1

1.7

27.00

29.59

umol/l

3.37

215

556

(3044941) Cell count panel - Synovial fluid

589

2394

2.00

51.40

1.5

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

242

655

2.99

51.33

2.1

2.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

299

909

2.66

51.26

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

461

1709

2.19

51.22

2.4

1.15

1.29

g/24h

0.53

221

802

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

531

2082

2.07

51.12

1.1

1.58

1.49

g/l

4.10

488

1855

(3020717) Zinc [Moles/volume] in Serum or Plasma

242

659

2.97

50.80

1.8

1.5

23.63

25.98

umol/l

0.52

234

626

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

188

438

3.47

50.77

2.4

1.6

13871.19

8068.63

e6/l

0.27

113

224

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

143

274

4.21

50.57

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

122

205

4.80

50.54

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

499

1921

2.11

50.41

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

313

983

2.58

50.32

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

255

720

2.87

50.21

1.7

1.5

10.36

8.69

ug/l

0.34

230

660

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

133

5.88

49.82

1.1

—

(3027944) Amphetamines [Presence] in Urine

1200

6088

1.61

49.58

3.5

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1668

9115

1.50

49.50

1.1

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

541

2164

2.03

49.36

1.2

1.1

118.60

117.26

0.37

489

1935

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

232

628

2.99

49.23

3.5

3.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

191

463

3.33

48.57

1.7

3.1

1.35

1.03

ug/l

1.06

180

444

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

185

440

3.40

48.44

1.7

1.9

27.96

26.95

0.44

174

425

(3030313) Adrenal Ab [Titer] in Serum

118

6.15

48.27

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

118

6.15

48.27

3.3

3.1

39.97

38.93

umol/l

0.14

(3003338) MCHC [Mass/volume]

21191

160247

1.22

48.22

37.2

14.4

330.92

332.50

g/l

109.18

20981

158875

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

980

4759

1.68

48.08

1.1

6.06

6.54

u/ml

0.13

608

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

205

523

3.17

48.06

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

303

959

2.56

47.98

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

303

964

2.54

47.48

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

112

6.27

47.47

3.6

1.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

340

1144

2.41

47.33

1.3

14.62

13.63

u/l

0.31

305

1073

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

589

2469

1.94

47.08

1.2

1.1

18.65

10.70

au/ml

0.67

154

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

113

6.21

47.08

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

186

453

3.32

46.97

1.8

2.0

10.53

11.58

0.51

172

430

(21494434) Karyotype in Bone marrow

354

1220

2.35

46.74

1.2

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

413

1522

2.20

46.60

2.5

2.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

171

399

3.46

46.12

1.4

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

242

697

2.81

46.01

2.9

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

391

1419

2.23

45.79

1.3

1.40

1.44

nmol/l

0.26

351

1277

(3002331) Protein [Mass/volume] in Peritoneal fluid

141

289

3.94

45.72

1.4

80.02

27.49

g/l

0.59

101

235

(1761868) Lipid panel - Serum or Plasma

7022

65875

0.81

45.64

3.3

2.7

—

(3017569) Oxygen content in Arterial blood

226

630

2.90

45.59

2.1

2.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

406

1500

2.19

45.54

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

140

5.47

45.42

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

105

6.30

44.98

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

424

1603

2.14

44.91

1.6

1.4

24.47

31.22

iu/ml

0.49

(3024932) HLA-DR beta [Type]

160

368

3.51

44.11

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

555

2335

1.93

43.91

1.4

1.3

—

(3024471) HLA-A [Type]

161

374

3.48

43.74

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

111

6.03

43.71

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

455

1789

2.06

43.54

1.5

1.7

4050.00

2446.98

titre

—

(3044007) Cell count panel - Peritoneal fluid

168

405

3.35

43.15

2.4

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

142

5.28

42.87

1.6

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

134

279

3.88

42.57

1.1

1.0

7.49

6.99

mg/g

0.32

125

266

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

222

640

2.80

42.18

2.8

2.6

42.09

40.41

0.61

134

345

(3036603) Volume of Urine

306

1040

2.38

41.73

1.6

1.5

1870.55

1905.25

0.27

296

1005

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

188

499

3.04

41.34

1.4

16.03

15.18

pmol/l

0.41

158

412

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

341

1222

2.26

41.21

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4772

31576

1.26

41.05

1.7

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

483

1988

1.97

40.76

1.1

—

(3047189) Immunofixation for 24 hour Urine

215

623

2.79

40.49

1.6

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

144

328

3.54

40.32

2.2

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

198

552

2.90

40.00

1.7

1.5

4372931.27

2096843.67

iu/ml

0.72

(3000060) B lymphocytes [#/volume] in Blood

143

326

3.54

39.99

1.7

2.0

200.00

1671.62

e6/l

1.15

185

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.26

39.87

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

223

665

2.71

39.80

1.3

1.2

145.38

164.68

mmol/24h

2.54

223

665

(3029634) Reagin Ab [Titer] in Serum by VDRL

503

2117

1.93

39.80

1.8

2.0

11.67

7.24

titre

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

174

452

3.11

39.69

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

144

332

3.50

39.61

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

141

5.09

39.46

1.7

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

191

526

2.93

39.44

2.1

2.0

64.48

61.67

ug/l

0.19

184

513

(3017315) Amylase [Enzymatic activity/volume] in Urine

245

772

2.57

39.25

1.2

173.97

361.95

u/l

2.53

229

716

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

294

1014

2.35

38.84

1.3

359.29

511.90

titre

0.31

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

223

674

2.67

38.80

3.6

3.7

—

(3029075) Extractable nuclear Ab panel - Serum

162

410

3.19

38.58

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

144

338

3.44

38.58

1.8

1.3

12.23

13.57

g/l

0.92

106

259

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

407

1607

2.05

38.57

1.2

1.1

95.31

95.17

0.03

381

1497

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

136

308

3.56

38.43

1.3

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

286

980

2.36

38.35

1.3

64.44

52.69

titre

0.30

(3006270) Folate [Moles/volume] in Blood

371

1418

2.12

38.30

1.2

1.1

346.85

353.16

nmol/l

0.20

267

1211

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

125

268

3.76

38.19

1.4

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

446

1827

1.98

38.18

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

529

2296

1.87

38.15

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

375

1444

2.10

37.98

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.20

37.91

2.1

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1381

7662

1.47

37.86

1.4

1.3

25.61

27.93

iu/l

1.75

1176

6635

(3016228) CD19 cells/100 cells in Blood

167

437

3.09

37.66

2.2

1.9

8.12

9.81

0.86

160

424

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

216

656

2.66

37.26

1.7

1.8

157.98

139.87

2.18

202

611

(3028433) Virus identified in Specimen by Culture

159

407

3.15

37.20

1.2

1.1

—

(40768443) Skin Pathology biopsy report

1382

7712

1.46

36.77

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

167

444

3.04

36.68

1.3

1.2

0.64

0.54

g/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

438

1812

1.96

36.48

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

188

539

2.82

36.17

3.1

2.1

—

(3035880) pH of Pleural fluid

254

848

2.42

36.10

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

161

426

3.05

35.67

2.2

1.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

113

238

3.83

35.42

1.1

3.29

12.10

pmol/l

0.47

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

822

4128

1.62

35.39

2.1

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

516

2279

1.84

35.25

1.1

—

(40768446) Kidney Pathology biopsy report

184

529

2.81

35.23

1.8

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

5.50

35.17

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

151

389

3.13

34.99

1.6

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

254

861

2.39

34.94

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

323

3.35

34.53

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

138

343

3.25

33.90

1.4

1.2

16.61

16.85

umol/l

0.21

129

304

(40762365) Oxygen content in Arterial blood by calculation

107

225

3.84

33.64

3.4

2.8

15.11

14.76

ml/dl

0.48

208

(3045424) Erythrocytes [Presence] in Urine

585

2734

1.74

33.08

1.6

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

168

4.32

33.05

1.4

1.6

130.35

109.07

ug/l

0.77

135

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

181

536

2.73

32.84

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

305

1148

2.15

32.82

2.2

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

130

4.84

32.75

1.1

1.62

1.80

umol/24h

0.51

130

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

240

819

2.37

32.57

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6804

47679

1.19

32.08

4.3

4.4

22.18

22.16

0.04

3218

23840

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

355

1430

2.01

31.95

1.6

1.5

24.40

31.36

3.36

230

855

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

143

4.57

31.83

2.2

2.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

221

736

2.43

31.65

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

201

3.89

31.14

1.2

1.4

888.43

154.14

ng/l

0.42

125

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

187

4.01

31.08

5.5

5.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

316

1233

2.07

31.02

3.1

2.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

214

710

2.44

30.91

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

229

786

2.35

30.71

7.1

11.2

—

(3002256) Pathology report gross observation

3604

23844

1.25

30.17

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

497

2277

1.77

30.16

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

7345

52057

1.18

29.95

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

172

4.08

29.74

1.3

1.2

41.09

53.60

1.16

(3024869) Neuronal Ab [Presence] in Serum

107

247

3.49

29.51

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

114

276

3.33

29.25

1.8

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24205

187791

1.19

29.09

5.3

4.7

2.55

2.77

mmol/l

245.30

22106

172884

(3012565) Volume of 24 hour Urine

223

776

2.32

29.02

1.9

2.2

1910.93

1973.53

0.37

190

677

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

104

5.04

28.60

1.2

1.4

13.73

13.89

pmol/l

0.02

(40768795) Lymph node Pathology biopsy report

285

1106

2.08

28.43

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

131

354

2.99

28.12

1.1

1.2

302.33

298.31

pmol/l

0.04

266

(37021550) Renin [Units/volume] in Plasma --upright

117

296

3.19

28.03

1.4

1.3

83.38

64.47

mu/l

0.38

226

(3008898) HLA-B27 [Presence]

980

5397

1.48

27.88

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

243

895

2.19

27.69

2.9

3.1

21.92

27.74

mu/l

1.47

221

846

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

143

412

2.80

27.40

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

731

8886

0.65

27.32

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

749

3916

1.55

27.25

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

199

685

2.35

26.59

1.1

3.86

13.57

u/ml

1.14

(3052592) Norovirus Ag [Presence] in Stool

110

277

3.20

26.58

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

616

3096

1.61

26.53

2.0

1.8

191.66

193.21

pmol/l

0.13

575

2922

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

163

516

2.55

26.06

1.4

1.5

447.78

819.58

mu/l

1.00

156

494

(40761539) Cells [Type] in Urine sediment by Light microscopy

138

401

2.78

26.06

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

292

1182

2.00

26.03

1.3

1.2

45.97

45.79

u/ml

0.00

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

172

3.84

25.97

2.2

1.8

—

(40768441) Liver Pathology biopsy report

278

1107

2.03

25.93

1.6

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

286

1151

2.01

25.91

1.3

1.2

22.37

42.80

u/ml

1.50

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

285

1147

2.01

25.82

1.3

1.2

60.86

67.63

u/ml

0.19

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

165

529

2.52

25.71

1.4

1.5

73.89

72.39

0.74

158

507

(3005570) Glucose [Moles/volume] in Urine

389

1745

1.80

25.42

2.0

1.8

—

0.30

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

22750

176124

1.16

25.29

4.3

3.8

1.34

1.27

mmol/l

34.60

20608

160749

(3028717) Thiamine [Mass/volume] in Blood

126

4.35

25.29

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

147

4.06

25.21

1.3

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

191

3.63

25.16

1.3

1.4

8.38

246161.51

nmol/l

1.73

156

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

218

3.44

25.14

1.2

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

152

474

2.59

25.07

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

497

2400

1.68

25.06

1.5

0.27

0.45

nmol/l

8.87

374

1886

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

275

1111

2.00

24.68

1.3

1.69

2.38

u/ml

0.42

156

625

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

155

494

2.53

24.48

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

115

313

2.96

24.45

1.4

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

797

4328

1.49

24.34

2.2

2.3

158.23

95.94

ug/min

2.40

416

2580

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3360

22562

1.22

24.10

12.4

5.9

—

(3014891) Appearance of Pleural fluid

205

3.46

24.03

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

179

3.65

23.89

2.1

2.3

1.21

1.81

mmol/l

1.15

129

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

422

1976

1.73

23.85

1.7

1.5

63.94

56.34

3.55

272

1210

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

151

484

2.52

23.59

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

528

2638

1.62

23.35

1.1

61.24

4903.57

iu/ml

0.65

115

562

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

150

482

2.51

23.32

1.8

1.9

193.17

160.74

2.02

144

447

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

600

3095

1.57

23.22

1.9

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

206

3.41

23.20

2.1

1.8

—

(3034988) Calcium [Moles/volume] in Capillary blood

106

284

3.01

23.18

1.8

2.0

1.18

1.19

mmol/l

0.63

100

272

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

212

796

2.15

23.13

1.1

31.63

22.09

u/l

1.61

192

718

(3018851) Theophylline [Moles/volume] in Serum or Plasma

129

4.12

22.99

1.8

1.7

42.55

40.88

umol/l

0.20

129

(40757373) Influenza virus identified in Isolate

102

269

3.06

22.91

1.5

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

121

353

2.77

22.75

2.4

3.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

471

2303

1.66

22.70

1.4

1.3

26.77

26.93

u/l

0.04

398

1884

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

210

796

2.13

22.39

1.1

94.97

83.60

u/l

0.94

190

721

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

264

1093

1.95

22.16

1.3

1.2

1.83

10.78

u/ml

2.10

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

4.13

21.99

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

123

4.13

21.99

5.9

7.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

146

478

2.46

21.86

1.2

1.1

105.22

108.98

0.53

138

423

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.26

21.74

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

825

4616

1.45

21.70

1.9

1.6

43.44

43.04

nmol/l

0.15

809

4479

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

142

461

2.49

21.65

1.1

87.69

91.18

0.49

197

(3014148) Varicella zoster virus Ab [Titer] in Serum

406

1936

1.70

21.53

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

225

3.19

21.46

1.6

1.9

100.97

50.63

pmol/l

0.49

191

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.22

21.11

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

327

1475

1.79

21.08

1.4

171091.59

116072.43

e6/l

0.61

228

999

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

444

2181

1.65

21.06

2.6

1.9

25.40

29.23

mg/l

0.64

115

584

(3001686) Cold agglutinin [Titer] in Serum or Plasma

224

3.17

21.00

1.2

1.3

62.18

188.56

titre

0.66

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

348

1601

1.76

20.99

1.1

3.11

1.69

iu/ml

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

107

4.29

20.92

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

216

852

2.05

20.79

2.2

2.1

81.05

86.10

ug/min

0.06

181

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

227

915

2.00

20.60

1.6

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

142

474

2.42

20.44

1.1

89.47

90.26

0.11

196

(3050129) First trimester maternal screen panel - Serum or Plasma

478

5974

0.64

20.39

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

5.60

20.23

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

222

894

2.01

20.21

1.5

1.2

4.19

5.00

umol/l

2.58

202

829

(3003129) Base excess in Capillary blood by calculation

119

367

2.62

20.18

1.7

1.8

1.21

0.39

mmol/l

1.13

104

346

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

509

2618

1.57

20.02

4.0

3.1

81.56

34.47

u/ml

2.22

488

2524

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.57

20.01

1.1

1.0

—

mmol/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.94

19.92

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

5.03

19.89

1.0

—

(3034426) Prothrombin time (PT)

145

495

2.36

19.89

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

119

4.00

19.78

1.1

—

(3024263) Appearance of Synovial fluid

213

853

2.02

19.71

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.97

19.60

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4875

34421

1.17

19.56

3.0

3.1

0.82

0.79

ug/l

0.57

3400

23101

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

319

1468

1.76

19.27

2.1

2.0

2.45

2.60

u/field

0.15

141

599

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2675

17937

1.22

19.24

2.2

1.9

—

(4212803) Bone marrow aspirate examination

129

3.81

19.21

1.1

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

401

5136

0.62

19.12

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1434

8968

1.30

18.82

3.8

3.2

82.80

48.89

u/ml

2.15

1370

8662

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

106

4.10

18.77

1.3

1.1

56.23

43.51

mg/l

0.52

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

6.48

18.71

1.5

431.24

618.45

nmol/l

0.74

(3006576) Bicarbonate [Moles/volume] in Blood

156

565

2.23

18.70

5.3

6.0

24.64

25.05

mmol/l

0.50

144

515

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

219

905

1.95

18.58

1.1

1.07

ratio

0.02

316

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

216

3.06

18.55

2.4

2.5

62.95

39.36

mg/l

0.60

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

155

562

2.23

18.54

1.4

64.43

64.74

0.04

122

475

(3005033) Fetal Nuchal fold Thickness US

284

3920

0.58

18.38

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

153

3.48

18.26

2.0

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

285

3923

0.58

18.26

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

112

3.96

18.24

9.1

6.7

0.35

0.36

umol/l

0.02

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

375

4824

0.62

18.24

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

165

3.37

18.22

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

375

4822

0.62

18.21

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

295

4016

0.59

18.11

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

375

4814

0.62

18.08

1.4

—

(3007463) Buprenorphine [Presence] in Urine

6.90

17.97

9.3

4.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

374

4791

0.62

17.87

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

106

329

2.60

17.81

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.75

17.77

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

130

446

2.35

17.70

1.2

1.3

572.08

186.63

ug/l

0.69

251

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

4.30

17.69

1.3

1.1

19.71

21.04

—

(40765096) Chromosome analysis panel by Banding

285

2.72

17.59

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

208

864

1.94

17.43

1.6

1.31

1.23

nmol/l

0.39

150

688

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

5.19

17.37

1.1

1.0

2.14

2.51

u/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

221

2.95

17.29

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.81

16.85

3.6

3.1

2.35

2.36

mg/l

0.02

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

168

3.21

16.48

1.1

1.0

0.02

0.44

u/ml

1.48

109

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

23565

184317

1.13

16.41

4.8

4.2

4.39

4.67

mmol/l

300.11

21643

170583

(3034891) Synovial lining cells/100 cells in Synovial fluid

182

739

1.99

16.31

1.7

1.4

3.48

3.71

0.09

152

(3011544) Albumin [Mass/volume] in Pleural fluid

134

3.49

16.17

1.2

1.1

15.87

18.63

g/l

1.71

124

(42529582) MDA5 Ab [Presence] in Serum by Line blot

107

351

2.46

16.10

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

107

351

2.46

16.10

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

107

351

2.46

16.10

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

107

351

2.46

16.10

1.1

—

(3000285) Sodium [Moles/volume] in Blood

196

3.00

16.05

1.4

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

192

3.02

16.02

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.17

16.00

1.5

1.6

1.91

1.82

mg/l

0.03

(3050794) Legionella sp Ab [Presence] in Serum

3.95

15.91

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

510

2765

1.49

15.87

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.99

15.79

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

167

669

2.01

15.56

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

449

2391

1.52

15.24

1.1

2.93

3.49

u/ml

0.35

139

1156

(3002621) Streptococcal DNAse B [Units/volume] in Serum

132

3.42

15.18

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

6.39

15.15

1.1

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

133

494

2.17

15.11

1.5

1.4

2.78

2.84

0.03

105

426

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

7.72

15.08

1.9

1.7

196.42

408.13

nmol/l

0.66

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.03

15.00

1.4

1.3

45.41

39.51

0.32

(3013336) Amino acids [Identifier] in Serum or Plasma

5.62

14.91

2.2

2.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

104

350

2.40

14.86

4.0

7.0

67.14

72.01

0.88

287

(43055514) Macroprolactin [Presence] in Serum or Plasma

113

395

2.31

14.83

1.5

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

134

504

2.14

14.77

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2892

20014

1.18

14.60

2.3

2.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

196

2.88

14.36

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.08

14.21

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

7.12

14.15

1.1

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

111

3.56

14.11

3.0

3.1

1.45

1.29

mg/l

0.21

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

23333

182834

1.12

13.98

4.7

4.2

1.39

1.48

mmol/l

167.97

21272

168296

(3023383) Lactate [Moles/volume] in Pleural fluid

130

495

2.12

13.92

1.3

4.05

3.62

mmol/l

0.45

118

457

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

0.40

0.77

mg/l

0.92

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

1.61

2.11

mg/l

0.23

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

2.63

4.22

mg/l

0.99

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.93

13.91

1.2

1.5

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

2.43

2.72

mg/l

0.12

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

1.71

1.96

mg/l

0.09

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

1.99

1.87

mg/l

0.04

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

1.20

0.89

mg/l

0.19

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

1.54

1.93

mg/l

0.28

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.93

13.91

1.5

1.6

2.99

3.06

mg/l

0.02

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.08

13.88

1.1

1.37

1.02

u/field

1.61

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

218

2.74

13.86

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

213

966

1.78

13.69

1.8

1.7

1.52

2.57

u/field

2.36

160

676

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

105

370

2.29

13.58

1.5

0.32

0.41

ug/l

1.65

225

(3043410) Blood group antigens tested for on Red Blood Cells

117

433

2.18

13.47

1.7

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.69

13.38

1.3

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.20

13.32

1.3

1.2

2.12

0.89

0.55

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

224

1041

1.74

13.26

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.08

13.21

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

320

2.37

13.15

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.76

13.10

1.3

1.4

15.69

17.41

pmol/l

0.21

(3046861) Legionella sp Ag [Presence] in Urine

4.42

13.03

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

4.42

13.03

2.5

1.5

205.30

192.76

ug/g

0.13

(3036071) Salmonella sp Ab [Titer] in Serum

112

415

2.18

12.88

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

150

621

1.95

12.84

1.1

1756.72

1491.16

miu/ml

1.60

150

621

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

4.14

12.76

1.2

1.1

37.63

58.75

u/l

1.84

(3020491) Glucose [Moles/volume] in Blood

263

1292

1.64

12.70

1.9

7.53

6.71

mmol/l

2.99

194

916

(3004775) Volume in Urine collected for unspecified duration

290

1462

1.60

12.62

2.1

2.2

711.93

652.96

1.17

166

1002

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

108

3.43

12.61

6.9

4.4

—

(3017509) Phencyclidine [Presence] in Urine

145

3.06

12.56

2.6

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

317

2.34

12.56

1.3

1.1

72.05

69.30

0.15

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.17

12.51

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.83

12.49

1.4

1.3

12.85

10.09

0.44

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.74

12.48

2.7

2.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

318

2.33

12.47

1.3

1.1

89.17

84.72

0.28

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

129

3.18

12.47

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

217

2.64

12.44

1.5

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.87

12.36

1.2

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

196

2.71

12.23

4.8

4.5

41.14

45.25

ug/min

0.20

153

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

230

2.56

12.06

1.5

1.4

8.88

10.79

0.35

119

(3000919) Neutrophils/100 leukocytes in Pleural fluid

116

448

2.09

12.05

1.5

1.3

21.77

19.16

0.49

100

412

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

181

2.76

11.87

1.3

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

116

451

2.07

11.85

1.4

68.19

53.70

4.26

382

(3018133) Calcium [Moles/volume] in Urine

237

2.52

11.84

2.0

2.5

2.78

2.65

mmol/l

0.20

217

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6514

48259

1.11

11.58

1.7

1.6

1.44

1.34

mmol/l

15.98

5472

40450

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1356

8938

1.23

11.51

1.9

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.81

11.49

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

116

3.19

11.33

1.4

1.2

16.18

14.11

nmol/l

0.26

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.45

11.11

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

385

2134

1.46

10.89

2.1

10.95

6.73

umol/l

1.09

277

1555

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

116

3.12

10.72

2.9

2.3

58.63

59.96

0.07

(3011335) Digoxin [Mass/volume] in Serum or Plasma

116

3.12

10.72

2.6

2.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

355

1946

1.47

10.64

1.1

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

138

2.92

10.63

1.3

1.2

91.70

114.67

ug/l

0.58

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

161

2208

0.58

10.40

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

4.03

10.31

1.0

1.2

0.38

0.48

umol/24h

0.19

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

321

2.18

10.21

2.3

2.6

7.20

7.63

mmol/l

0.47

176

(3036670) Protein [Mass/volume] in Synovial fluid

116

479

1.95

10.12

1.2

38.72

39.73

g/l

0.36

247

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1665

11343

1.19

10.07

2.0

1.9

—

(3048879) Bone marrow aspiration report

104

414

2.02

10.05

1.8

1.6

—

(1002224) Polysomnography panel

1058

6895

1.24

10.02

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

267

3228

0.66

9.96

1.4

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

146

654

1.80

9.93

2.7

2.1

22.12

358.10

ug/l

1.53

137

611

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

4.36

9.87

1.1

1.0

129.93

216.61

pmol/l

0.66

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.44

9.70

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

288

1547

1.50

9.59

3.7

4.9

166.08

122.51

u/ml

0.31

485

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

156

2.69

9.54

1.3

1.5

—

(4034850) Laboratory test

901

5810

1.26

9.40

13.2

9.3

—

(3000034) Microalbumin [Mass/volume] in Urine

290

1572

1.49

9.26

3.4

3.0

44.45

49.77

mg/l

0.19

216

1127

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.19

9.22

2.1

2.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

147

676

1.75

9.20

1.0

1.1

98.75

95.28

0.57

119

521

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

218

2.37

9.09

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

12.88

9.06

1.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

370

2.03

9.05

1.4

20.01

20.70

0.08

320

(3045683) HLA typing for celiac disease panel - Blood or Tissue

199

997

1.61

9.05

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

349

3939

0.71

9.01

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

100

3.06

8.81

2.2

2.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

290

1594

1.47

8.68

1.3

9.41

8.34

mmol/l

3.36

271

1528

(3012898) Urea [Moles/volume] in Urine

141

2.68

8.66

1.3

1.5

178.67

154.79

mmol/l

0.60

127

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

4.88

8.64

6.5

6.2

0.80

1.57

mg/l

1.07

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.88

8.64

2.2

2.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.88

8.54

1.0

0.16

0.07

u/ml

0.40

(4094501) Cardiovascular stress test using bicycle ergometer

743

4742

1.27

8.50

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.52

8.38

1.2

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

232

2.26

8.34

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

918

6016

1.23

8.33

2.1

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

233

2.25

8.26

2.9

2.8

—

(40758292) HTLV I+II Ab panel - Serum

204

2.33

8.15

1.4

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

389

4238

0.74

8.10

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

190

2.37

8.07

1.2

1.3

90.62

242.13

u/l

0.46

140

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

110

2.86

8.07

1.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

7.28

8.06

1.8

1.7

147.69

275.60

nmol/l

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

432

1.88

8.05

1.6

—

514.00

iu/ml

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

863

0.43

7.97

1.1

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

107

2.86

7.89

1.0

1.1

6.88

11.37

u/l

1.00

107

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

218

2.25

7.83

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

149

2.54

7.82

1.2

1.1

21.51

19.91

u/l

0.17

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.73

7.82

1.1

1.27

0.93

u/field

0.80

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.61

7.78

5.0

5.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

269

3087

0.70

7.72

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

134

633

1.71

7.71

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2385

17060

1.14

7.61

1.6

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

553

1.75

7.55

1.2

1.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

119

2.71

7.54

1.5

1.3

1.03

1.97

ml/s/173m2

0.70

(3042010) Triglyceride [Moles/volume] in Pleural fluid

223

2.20

7.45

1.2

1.3

1.18

1.54

mmol/l

0.21

144

(44813793) Dust mix specific IgE antibody measurement

228

1234

1.49

7.45

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.94

7.40

1.7

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.37

7.27

1.8

2.1

—

(3024316) Viscosity of Plasma

3.43

7.25

1.5

1.8

1.61

1.92

mpas

0.79

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

108

2.76

7.23

2.6

3.3

28.62

35.56

pmol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

6.12

7.23

1.7

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1279

0.55

7.21

1.5

—

(3016750) Collection duration of Urine

198

1048

1.52

7.21

2.2

2.0

515.62

497.64

min

1.58

126

797

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.47

7.09

1.1

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.41

6.92

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

4.56

6.84

1.1

1.0

78.29

67.85

mu/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

202

1088

1.50

6.80

1.1

6.44

8.21

iu/ml

0.63

272

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.83

6.76

3.0

2.3

9.28

18.22

1.11

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.93

6.72

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

108

2.68

6.71

3.2

2.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.54

6.45

1.1

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

120

2.55

6.43

1.1

1.0

6.90

2.71

u/ml

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.27

6.28

1.0

1.2

3403.27

2162.63

ng/l

0.42

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

226

2.07

6.11

1.1

1.0

93.64

78.36

ug/l

1.71

178

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.81

6.11

1.2

—

(3018291) Platelet Ab [Presence] in Serum

7.04

5.98

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.02

5.91

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

241

2.01

5.85

1.4

1.5

5.05

5.47

nmol/l

0.34

232

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

3.81

5.84

1.0

0.17

0.37

u/ml

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.81

5.84

1.1

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.38

5.78

1.0

1.1

0.06

0.04

u/ml

0.17

(3021162) Amylase [Enzymatic activity/volume] in Specimen

232

2.01

5.73

2.3

2.8

1059.56

2140.19

u/l

0.64

211

(40759632) Porphyrins [Mass/mass] in Stool

9.83

5.71

1.0

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.91

5.70

1.1

1.0

5.88

5.06

mmol/l

0.24

(3001019) Free T4 and TSH panel - Serum or Plasma

971

9140

0.85

5.64

1.7

1.6

—

(3001729) Color of Synovial fluid

125

2.38

5.50

1.7

1.8

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.62

5.47

1.7

1.3

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

5.49

5.42

1.1

1.4

74.90

20.80

e6/l

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

6.54

5.35

1.0

0.16

0.41

u/ml

—

(3022475) Manganese [Moles/volume] in Blood

2.55

5.29

1.1

1.4

—

(4281824) Cell count and differential, peritoneal fluid

315

1923

1.32

5.26

1.3

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

128

2.33

5.24

1.0

0.10

0.35

u/ml

0.61

(3011325) HIV 1+2 Ab [Presence] in Serum

2.83

5.21

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

177

986

1.45

5.15

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

437

1.68

5.09

1.5

1.6

9.95

8.94

ug/l

1.36

437

(3015183) Erythrocyte sedimentation rate

154

837

1.48

5.09

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

599

3970

1.22

5.06

1.5

1.4

199.66

131.94

pmol/l

1.38

576

3867

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

227

1.95

5.03

1.1

1.3

27.50

42.62

mg/l

3.16

187

(44786800) Granulocytes/100 leukocytes in Body fluid

205

2.00

5.02

1.4

1.3

21.53

25.26

0.36

161

(3049233) Organic acids panel - Urine

5.81

4.96

1.2

1.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

137

2.23

4.92

1.1

1.0

1.26

3.03

u/ml

0.26

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.02

4.88

1.1

1.2

215.16

267.53

nmol/l

0.72

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

213

1.97

4.87

2.5

2.7

55.04

73.34

pmol/l

0.71

192

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

138

2.22

4.84

1.1

1.0

0.30

0.39

u/ml

0.09

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

572

5558

0.82

4.83

1.4

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

478

3112

1.24

4.81

1.1

3.95

5.48

u/ml

2.29

264

1627

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

108

2.39

4.81

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.76

4.79

3.8

3.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

529

3484

1.23

4.78

1.2

1.1

2.77

2.17

u/ml

0.46

287

1779

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.64

4.77

1.4

1.5

164.90

122.88

nmol/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.48

4.74

1.1

1.0

8.14

9.66

u/ml

0.16

(3032641) Amino acids panel - Urine

6.04

4.74

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

6.04

4.74

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.86

4.67

1.4

1.5

0.00

0.18

u/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

607

4063

1.21

4.67

5.0

3.0

27.76

27.93

mg/l

0.04

414

2579

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

357

1.71

4.65

2.5

2.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.66

4.64

8.6

7.9

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.47

4.63

1.4

0.78

0.58

u/field

—

(3013293) Extractable nuclear Ab [Presence] in Serum

240

1.88

4.62

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

168

2.06

4.60

1.3

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

6.32

4.52

7.3

2.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

496

1.59

4.52

1.1

8.65

15.45

u/ml

0.27

293

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

102

2.37

4.46

1.3

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

405

1.65

4.43

1.3

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

499

1.58

4.42

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

123

2.23

4.40

1.1

10.77

13.78

iu/ml

0.21

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

245

1.84

4.36

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

245

1.84

4.36

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

245

1.84

4.36

1.3

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

234

1.86

4.33

1.6

1.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.90

4.33

2.8

4.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

182

1056

1.39

4.30

1.1

0.38

2.55

u/ml

4.14

359

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

201

1.92

4.27

1.4

73.23

72.58

0.05

173

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

168

965

1.40

4.22

1.3

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.48

4.13

1.2

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.39

4.11

1.0

4.63

0.45

u/ml

0.44

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

143

2.08

4.10

1.0

0.27

0.06

u/ml

0.42

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.64

4.09

1.1

1.2

0.05

0.08

g/l

1.69

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

346

2219

1.26

4.05

1.6

1.5

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.51

4.04

1.0

0.13

0.32

u/ml

0.68

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

289

1.73

3.96

1.1

1.2

6.43

10.55

u/ml

0.30

219

(3002814) Trichinella spiralis Ab [Titer] in Serum

8.05

3.90

1.1

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.97

3.90

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.92

3.81

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.31

3.79

1.1

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1132

0.67

3.74

1.1

1.3

1.55

1.56

g/l

0.21

1132

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3463

29673

0.93

3.71

1.5

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

310

1.66

3.59

1.2

1.56

1.72

mmol/l

0.47

186

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.93

3.58

1.1

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

280

1.70

3.57

1.5

1.4

0.19

0.24

nmol/l

0.59

204

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

324

1.64

3.53

1.2

58.34

20.89

mg/l

0.41

243

(3010726) Horse dander IgE Ab [Units/volume] in Serum

435

2908

1.21

3.51

1.1

0.94

2.03

u/ml

5.08

248

1493

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

139

801

1.40

3.50

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.29

3.50

1.2

1.3

89.00

486.67

u/l

0.79

(3022229) Phosphate [Moles/volume] in Urine

2.33

3.50

2.7

22.61

18.16

mmol/l

0.54

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.74

3.49

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

503

1.51

3.49

2.7

2.9

121.78

149.39

au/ml

0.23

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

427

1.55

3.45

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

402

1.56

3.43

10.0

6.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

445

2989

1.20

3.42

1.1

1.32

1.10

u/ml

0.23

208

1309

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

200

1.81

3.41

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

4.73

3.41

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.39

3.41

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.41

3.32

1.3

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

2.87

3.27

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

107

2.11

3.26

1.9

0.56

0.47

0.10

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

544

1.47

3.26

3.2

3.5

7.90

7.75

mg/l

0.10

432

(3044009) aPTT.lupus sensitive (LA screen)

129

2.00

3.24

1.1

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

229

1.72

3.17

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.40

3.14

8.8

8.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.89

3.09

1.1

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

6.26

3.03

1.4

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.63

3.00

1.7

1.2

70.63

122.12

ug/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

344

2289

1.21

2.98

1.1

4.37

4.92

u/ml

0.22

154

977

(3035933) Granulocytes/100 leukocytes in Blood

411

1.51

2.95

2.6

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

299

1964

1.23

2.94

1.1

1.0

0.20

0.35

u/ml

0.90

104

544

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.95

2.92

1.5

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

107

2.03

2.89

1.0

1.1

4.57

1.05

u/ml

0.42

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

164

1.82

2.88

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

5.63

2.84

1.1

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

5.63

2.84

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

160

1.81

2.79

1.2

5.93

6.48

mmol/l

0.29

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

137

1.88

2.78

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

241

1.64

2.69

3.0

2.4

0.43

0.59

u/field

0.71

241

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.28

2.68

1.3

1.4

4.10

1.95

mu/l

0.42

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.36

2.60

22.6

8.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

201

1.68

2.56

2.2

2.6

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.11

2.52

1.3

1.00

1.19

u/field

1.02

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.62

2.51

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1967

16940

0.93

2.49

1.5

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

356

1.49

2.47

10.2

7.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.37

2.42

1.0

14.50

14.89

umol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.12

2.42

1.6

1.7

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.04

2.41

1.1

1.2

40.64

32.73

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.04

2.41

1.1

1.2

18.60

26.26

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

165

1040

1.28

2.40

1.0

1.1

0.45

5.25

u/ml

1.30

279

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

111

1.89

2.32

1.0

1.4

0.20

7.97

u/ml

0.87

(3014133) Dog dander IgE Ab [Units/volume] in Serum

359

2462

1.18

2.31

1.1

2.64

4.33

u/ml

2.45

186

1213

(3020650) Glucose [Presence] in Urine

448

1.42

2.31

1.7

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

369

1.46

2.29

5.4

6.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.02

2.24

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.93

2.20

1.4

1.8

0.73

0.71

umol/l

0.05

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

727

5255

1.12

2.19

1.3

191.24

229.44

miu/ml

1.92

273

2535

(3042628) Porphyrins [Moles/volume] in Urine

5.75

2.17

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.87

2.16

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.39

2.15

1.1

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.02

2.10

1.2

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.07

2.08

1.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

170

1.66

2.08

1.0

1.1

0.97

7.09

u/ml

1.38

133

(46236302) HLA-C [Type] by High resolution typing

2.78

2.07

1.0

—

(3013862) HLA-DP [Type]

2.78

2.07

1.0

—

(40760410) HLA-B [Type] by High resolution

2.78

2.07

1.0

—

(40763590) HLA-DQ beta [Type]

2.78

2.07

1.0

—

(40760409) HLA-A [Type] by High resolution

2.78

2.07

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

110

1.83

2.07

1.0

0.36

1.03

u/ml

1.50

(3019174) dRVVT (LA screen)

128

1.76

2.05

1.1

1.2

—

(3006598) pH of Arterial cord blood

133

0.36

2.03

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

5.03

2.00

1.0

1.1

29.20

20.13

umol/l

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

5.03

2.00

1.4

1.6

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

5.03

2.00

1.4

1.6

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.52

2.00

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.68

1.99

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.53

1.96

1.4

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

410

1.39

1.93

1.5

1.3

31.67

39.90

0.91

260

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

493

1.36

1.91

2.0

7.72

9.61

mg/l

2.69

406

(3021691) Plasmodium malariae Ab [Titer] in Serum

4.47

1.85

2.6

—

(3006462) Nitrate [Presence] in Urine

139

891

1.26

1.85

3.5

3.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

103

1.80

1.83

6.1

2.8

13.67

12.82

0.07

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

121

1.73

1.83

1.5

5.3

—

(3001556) Androgen free Index in Serum or Plasma

152

1.64

1.81

1.6

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.93

1.77

1.7

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

4.02

1.72

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.02

1.72

1.0

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

2.44

1.63

1.0

—

1.18

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

365

0.64

1.62

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

196

1.52

1.61

1.1

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.66

1.60

1.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

3.66

1.60

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

171

1.55

1.58

1.0

1.1

0.16

3.72

u/ml

3.39

139

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

156

1039

1.21

1.52

5.8

6.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

327

1.38

1.50

1.1

4.87

3.92

u/ml

0.07

275

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.35

1.49

1.0

—

(4146454) Self-monitoring of blood glucose

295

2078

1.14

1.46

2.5

2.7

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.41

1.46

2.2

—

(3041184) Isoniazid [Presence] in Urine

2.84

1.45

4.5

2.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.16

1.45

2.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

137

1.59

1.43

4.5

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

313

0.64

1.40

6.6

6.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

313

0.64

1.40

3.3

3.4

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.18

1.34

2.5

1.3

0.87

0.41

—

(40768793) Breast Pathology biopsy report

542

3981

1.10

1.33

1.3

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.54

1.29

1.0

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

142

1361

0.84

1.29

1.5

1.6

8.24

7.72

mmol/l

1.42

135

1304

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

400

1.31

1.28

1.7

47.16

121.66

au/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

296

1.36

1.27

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

116

1.60

1.27

1.0

—

(40762814) Titanium [Mass/volume] in Blood

324

1.34

1.26

2.0

2.3

3.72

3.21

ug/l

0.47

104

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.85

1.26

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2685

20824

1.04

1.21

1.6

1.7

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.68

1.21

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

710

6145

0.93

1.19

1.4

—

(3025577) Chromium [Mass/volume] in Blood

164

1132

1.17

1.14

1.9

2.1

2.30

2.31

ug/l

0.01

132

948

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

241

1.37

1.12

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

119

802

1.19

1.10

5.3

5.2

407.45

5802.45

u/ml

0.60

136

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

860

6499

1.07

1.08

1.9

1.6

4.11

3.57

mg/l

0.75

666

4577

(3002523) Influenza virus A Ag [Presence] in Specimen

352

2564

1.11

1.08

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

512

1.24

1.08

1.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.17

1.06

1.1

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

167

1163

1.16

1.06

1.9

2.0

3.45

3.67

ug/l

0.17

147

1073

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.77

1.06

3.0

3.2

—

0.00

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2961

23085

1.04

4.7

4.5

32.70

32.52

0.39

2166

15549

(3003740) Influenza virus B Ag [Presence] in Specimen

351

2564

1.10

1.03

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

136

937

1.17

1.00

1.1

1.0

2.09

0.64

u/ml

0.35

255

(3034092) Cytoplasmic Ig cells/100 cells in Blood

220

1.35

0.97

14.3

6.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.97

0.0

1.1

—

67.78

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.97

0.0

1.1

—

32.29

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.94

0.96

1.3

1.0

1.57

2.00

—

(3008607) Semen analysis panel

1.61

0.95

1.3

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

126

1.47

0.94

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.54

0.91

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.63

0.89

1.0

0.14

0.75

u/ml

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.52

0.88

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

262

2325

0.91

0.86

1.5

1.3

3.36

3.80

ug/l

0.33

228

2068

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

287

0.73

0.84

1.4

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

377

1.24

0.82

1.5

1.2

—

(36303858) Crystals [Presence] in Urine

1.86

0.80

1.2

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.79

0.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

207

0.70

0.76

1.1

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

276

2037

1.09

0.73

1.4

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.01

0.72

1.6

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

107

1.43

0.71

1.2

1.0

0.28

0.23

u/ml

0.09

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

138

0.64

0.71

1.0

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.68

0.71

1.0

0.02

0.09

u/ml

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.48

0.71

1.0

1.1

0.01

2.60

u/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

121

1.40

0.70

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

506

1.18

0.67

1.0

1.1

11.09

11.58

u/ml

0.07

285

(3032868) Hemoglobin electrophoresis panel in Blood

152

1.32

0.63

1.6

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

480

0.84

0.58

2.6

2.9

—

(3010937) Rubella virus Ab [Presence] in Serum

1.40

0.56

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.54

0.55

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.61

0.55

1.0

1.4

2.08

mmol/24h

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

100

1.37

0.53

1.4

1.3

399.59

318.60

umol/24h

0.42

100

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

363

1.18

0.51

3.5

2.5

84.15

105.52

ng/l

0.71

170

(3027874) Urate [Moles/volume] in Urine

1.52

0.51

1.1

1.79

1.73

mmol/l

—

(40768800) Prostate Pathology biopsy report

451

3815

0.95

0.49

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

652

1.12

0.49

1.7

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.52

0.48

3.4

4.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.37

0.46

1.0

0.20

0.52

u/ml

—

(46235168) Fasting glucose [Moles/volume] in Blood

192

1.22

0.42

3.0

1.4

7.73

7.16

mmol/l

0.42

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

295

2506

0.95

0.41

1.3

7.06

7.19

mmol/l

0.33

253

2186

(3028714) Urate [Moles/time] in 24 hour Urine

1.49

0.41

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

286

1.15

0.35

5.9

6.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

737

1.08

0.30

1.3

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

111

831

1.08

0.29

1.0

1.1

11.21

9.33

u/ml

0.22

135

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

133

1003

1.07

0.29

1.3

1.4

5.72

5.70

mmol/l

0.06

124

953

(40758358) Immune stain study

1.30

0.28

1.0

—

(3022689) Creatine [Moles/volume] in Urine

514

0.91

0.28

1.6

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

522

0.91

0.27

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

105

1.23

0.27

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

159

1348

0.95

0.25

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

107

917

0.94

0.24

1.2

1.4

32.00

31.44

nmol/l

0.07

854

(3029612) Listeria sp Ab [Titer] in Serum

1.30

0.23

1.2

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

149

1.13

0.17

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

107

901

0.96

0.16

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

199

1.09

0.13

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

325

0.94

0.10

2.0

1.8

2.14

3.09

ug/l

0.47

198

(3041806) Other cells [#/volume] in Blood by Manual count

669

0.96

0.10

1.7

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

1.15

0.10

4.2

8.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.86

0.07

1.5

1.3

2.04

1.81

mg/l

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

207

1.05

0.05

1.6

1.2

22.55

20.60

mmol/l

1.09

175

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

113

894

1.02

0.04

1.9

1.6

—

(3025130) Human papilloma virus identified in Specimen

305

2474

0.99

0.04

1.6

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

163

1306

1.00

0.00

1.3

145.59

170.47

pmol/l

2.10

163

1306

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.99

0.00

1.0

1.1

9.28

8.38

mmol/l

1.15

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.3

—

18.36

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.84

0.00

1.2

1.1

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.87

-0.00

5.8

5.5

0.10

0.29

mmol/l

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_MALAI_FATIG – Malaise and fatigue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malaise and fatigue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malaise and fatigue (R18_MALAI_FATIG)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints